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FOREWORD
The Life Sciences Research Office (LSRO), Federation
of American Societies for Experimental Biology (FASEB), provides
scientific assessments of topics in the biomedical sciences.
Reports are based upon comprehensive literature reviews and the
scientific opinions of knowledgeable investigators engaged in
work in specific areas of biology and medicine.
This technical report was developed for the National
Aeronautics and Space Administration (NASA) in accordance with
the provisions of Contract NASW 3616. It was prepared and edited
by Matthew N. Levy, M.D., Chief of Investigative Medicine, the
Mt. Sinai Medical Center, Cleveland, Ohio, who served as Key Bio-
medical Scientist for this effort and John M. Talbot, M.D., Senior
Medical Consultant, LSRO.
The LSRO acknowledges the contributions of the investi-
gators and consultants who assisted with this study. The report
reflects the opinions expressed by an ad hoc study group that
met at the Federation on July 6-7, 1982. The study participants
reviewed a draft of the report and their various viewpoints were
incorporated into the final report. The study participants and
LSRO accept responsibility for the accuracy of the report; how-
ever, the listing of these individuals in Section VIII does not
imply that they specifically endorse each study conclusion.
The report was reviewed and approved by the LSRO Advisory
Committee (which consists of representatives of each constituent
Society of FASEB) under authority delegated by the Executive Com-
mittee of the Federation Board. Upon completion of these review
procedures, the report was approved and transmitted to NASA by the
Executive Director, FASEB.
While this is a report of the Federation of American
Societies for Experimental Biology, it does not necessarily
reflect the opinion of each individual member of the FASEB
constituent Societies.
(_te) i Kenneth D. Fisher, Ph.D.
Director
Life Sciences Research Office
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SUMMARY
One of the unresolved biomedical problems of space flight
is a lack of means to prevent or control the "deconditioning" of
the cardiovascular system that occurs during "adaptation" to the
environmental influences of space flight. Evidence of cardiovas-
cular deconditioning obtained directly from observations of astro-
nauts and cosmonauts during flight and postflight has accumulated
since it was first reported following the 9-hour Mercury mission.
Since completion of the Skylab space flight program in 1974, sub-
stantial amounts of additional data on the cardiovascular effects
of long orbital flights and ground-based simulation studies have
been reported. Although human adaptability to the space flight
environment appears adequate for missions lasting at least 6
months, important unresolved questions persist.
In order to ensure crew safety and mission accomplishment
in future manned space programs, NASA needs more precise data on
the nature and mechanisms of cardiovascular adaptation and decondi-
tioning that result from exposure to the space flight environment,
in particular to weightlessness, the dimensions and practical sig-
nificance of possible regressive changes in the myocardium and
other parts of the cardiovascular system, and the most efficient
methods of preventing or treating functional and possible organic
deterioration of the cardiovascular system.
Mechanisms of cardiovascular deconditioning
The basic cause of the cardiovascular deconditioning
response is generally agreed to be weightlessness, which results
in disappearance of the customary, gravity-induced, hydrostatic
pressure gradients throughout the body_ Immediately upon exposure
to zero-G a shift in regional blood volumes occurs towards the
most compliant segments of the circulation, i.e. the lungs, heart
and the systemic veins, which are only p2rtially filled when at
I-G. This regional volume change is presumably followed by a
change in total blood volume caused by transcapillary fluid move-
ments consequent to the elimination of gravitationally induced
intravascular and tissue pressure gradients. In a gravitational-
force environment such as that on planet Earth, such gradients are
present in all body positions and are proportional to the differ-
ences in vertical height of the various capillary beds in the
systemic and pulmonary circulations associated with any particular
body position. Suppression of vasopressin release accompanied by
a water diuresis and natriuresis are characteristic responses
early in simulated weightlessness, and have been postulated in
zero-G.
v
While the exact biologic mechanisms of the deconditioning
response subsequent to the rapid changes in regional blood volume
and increase in right atrial filling pressure, which are presumed
to occur at the onset of the zero-G environment, have not been
established, several possible hypotheses are either under investi-
gation or included in future research plans. These suggest: (i)
a decrease in overall blood volume subsequent to the presumed
increase in central venous pressure which occurs concomitantly
with the onset of the zero-G environment, (2) changes in shape and
position of the diaphragm and associated changes in lung volume,
(3) altered cardiac output and redistribution of systemic and pul-
monary blood flow and ventilation, (4) changes in venous compliance
and/or capacity, (5) possible changes in reflex control of cardio-
vascular function, (6) changes in the densities and sensitivities
of cardiovascular volume, pressure and neurohumoral receptors, (7)
altered peripheral sympathetic function and decreased adrenergic
responsiveness of vascular smooth muscle, (8) impaired release or
uptake of norepinephrine, (9) relative disuse of the lower extrem-
ities with loss of muscle pumping, and (i0) increased intracranial
pressure leading to changes in control and production of central
nervous system regulatory hormones. In addition, possible inter-
active effects on the cardiovascular system of abnormal environ-
mental responses of other organ systems and regulatory functions
may be significant.
Countermeasures
Attempts to prevent or control cardiovascular decondi-
tioning have involved inflight, reentry, and postflight measures
as well as experimental interventions during or after bed rest and
other ground-based analogues of weightlessness. These measures
have included inflight exercises and lower body negative pressure
(LBNP), venous occlusion, pre-reentry fluid and electrolyte replace-
ment, use of anti-G suits during and following reentry, and post-
flight supportive measures. In addition, drugs and hormones have
been tested experimentally.
Expert opinion is divided about the extent of protection
offered by such measures as vigorous, regularly scheduled exercise,
repeated LBNP, and pre-reentry fluid and electrolyte replacement.
However, from experience with long-term manned flights, Soviet
investigators are sufficiently convinced of the efficacy of such
measures that they consider their inclusion during long-term mis-
sions mandatory. However, some investigators regard such counter-
measures as marginally effective or noneffective in preventing the
cardiovascular deconditioning, particularly the orthostatic
intolerance, associated with weightlessness or its ground-based
models.
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In spite of variable and sometimes contradictory results
obtained during studies of countermeasures, certain approaches have
appeared promising enough to warrant further research and develop-
ment. Among these are dynamic exercise, static exercise, centrifu-
gation, prolonged LBNP stressing (4 h/d) combined with oral replace-
ment of fluids, and the use of anti-G suits or leotards.
Program assessment
The primary task in this review was evaluation of NASA's
ground-based research and technology program and identification of
opportunities for its improvement. One question of fundamental
importance is whether the biologic responses to the currently
available methods of simulating zero-G truly represent the effects
of weightlessness. One of the experts in the ad hoc Group firmly
believes that none of the ground-based models provides an adequate
simulation of the circulatory and subsequent effects of the agravic
environment (see Appendix). However, a majority of the study
participants regarded ground-based analogues of weightlessness as
useful approaches to the study of the general problems of cardio-
vascular deconditioning and the most feasible approach for con-
trolled experiments with statistically significant numbers of sub-
jects. With the caveat regarding validation of the ground-based
models by inflight study, NASA's current and planned program of
ground-based research is well formulated to accomplish its objec-
tives. However, the level of effort needs selective augmentation
to expedite the resolution of certain aspects of the problem.
Critical questions and suggested research
Questions deserving high priority concern: (i) whether
degenerative changes occur in the cardiovascular system during
medium- and long-term missions, in particular, a possible loss of
myocardial mass, (2) the nature and temporal development of changes
in cardiovascular regulatory control mechanisms, (3) possible
changes in the density and sensitivity of the pressure, volume, and
neurohumoral receptors in the cardiovascular system, (4) alterations
in vascular compliance and capacity, (5) associated changes in hemo-
dynamics, and (6) the nature of the redistributed blood flows.*
* One member of the LSRO ad hoc Working Group suggested that this
paragraph required altered emphasis (see Appendix, p.63).
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In order to facilitate the investigation of these prob-
lems, the state-of-the-art in methodology and instrumentation needs
substantial improvement. For instance, improved means are needed
for measuring non-invasively, in living subjects, such characteris-
tics as cardiopulmonary dimensions, heart chamber volumes, and myo-
cardial mass. Current methods for in vivo functional assessment of
cardiovascular mechanoreceptors must be improved as should methods
for measuring absolute changes in venous volume. Greater attention
should be given to the selection of the most suitable animal models
and to the design of animal experiments in such a way as to elimi-
nate, if possible, spurious influences that may result from equip-
ment and methodology employed. Finally, computer and other models
of the cardiovascular system offer possible improvements in experi-
mental design despite the lack of complete, explicit data on the
basic mechanisms of cardiovascular deconditioning.
Conclusions
The cumulative experience from manned space flight sug-
gests that the effects on the cardiovascular system are tolerable
and reversible, and do not interfere with inflight crew effective-
ness during missions lasting six or seven months. Postflight
orthostatic intolerance has occurred after all manned flights to
date, requiring supportive care to prevent possible injuries and
to aid in the process of readapting to Earth gravity. Whether
space missions of greater duration than heretofore will cause more
profound changes in the integrity of the cardiovascular system is
unknown. However, in view of the future likelihood of longer
manned missions, and until such time as a reliable understanding
of the basic mechanisms of cardiovascular deconditioning is
acquired and effective, practical countermeasures have been
developed and proved, the ad hoc Working Group on Cardiovascular
Deconditioning suggests that the NASA ground-based research and
technology program in cardiovascular deconditioning, reinforced
where feasible by incorporation of the suggestions contained in
this report, should be given a high priority in NASA's research
and technology plans.
viii
TABLE OF CONTENTS
Page
Foreword ....................... iii
Summary ...................... v
I. Introduction .................... 1
II. Objectives and Scope of the Study ......... 3
III. Overview of Cardiovascular Deconditioning ..... 5
A. Definition .................. 5
B. Cardiovascular Responses to Weightless-
ness and Simulated Weightlessness ...... 8
C. Countermeasures ................ 14
D. Related Factors and Physiologic Functions . . . 20
IV. NASA's Program of Ground-Based Research in
Cardiovascular Deconditioning .......... 23
V. Observations of the ad hoc Working Group
on Cardiovascular Deconditioning ......... 25
A Hemodynamic Factors - 25
B. Effects of Space Flight on Cardiovascular
System Receptors .............. 30
C. Catabolic, Atrophic, and Histopathologic
Changes ................... 32
D. Hormonal and Neurohumoral Factors ....... 34
E. Countermeasures ................ 35
F. Methodology .................. 38
VI. Proposed Priorities of Suggested Research
and Analysis ................... 41
VII. Literature Cited .................. 47
VIII. Study Participants ................. 59
ix
Page
IX. Appendix ..................... 61
Minority Opinion .................. 63
A. Alterations to page vii of the summary .... 63
B. Alterations to page I0 of the subsection
on cardiovascular responses to simulated
weightlessness ............... 63
C. Additions to page 41 of the section on
proposed research priorities ........ 67
D. Supporting literature citations for the
minority opinion .............. 67
x
I. INTRODUCTION
The record of achievement in manned space flight has been
magnificent and nearly faultless. The experiences of both the
United States and the Soviet Union have demonstrated man's adapt-
ability to the effects of the space environment for exposures as
long as 6 months without serious untoward medical effects (Soffen
and Gazenko, 1981).
However, significant physiologic changes do occur even in
relatively brief space flights measured in hours or days. A
"deconditioning" of the cardiovascular system is one important com-
plex of responses that results in remarkable, but transitory, func-
tional impairment of spacecrews immediately following return to
Earth (Berry, 1974; Berry et al., 1966; Dietlein, 1977; Kalinichenko
et al., 1976; Pestov and Geratewohl, 1975; Sandler, 1980; Vorob'yev
et al. , 1976). The functional impairment caused by the decondi-
tioning process is manifested primarily by orthostatic intolerance
when the subject assumes the upright posture. The resultant signs
and symptoms of cardiovascular instability include tachycardia,
labile arterial blood pressure, narrowed pulse pressure, presyncopal
symptoms, and syncope. It impairs other functions as well, such as
work capacity and maximal oxygen uptake during exercise.
While the range of time for return of cardiovascular func-
tions to preflight values has typically varied between 2 and 5 days,
one member of the crew of Apollo 15 required 13 days, and, after
one of the Soviet missions, full recovery of the cosmonauts required
as long as 30 days (Sandler, 1980). Such delayed recoveries have
not always been directly related to mission duration. Critical
questions have arisen on how long an astronaut can continue to
function efficiently and maintain acceptable physiologic status
inflight and whether any of the adaptive changes that characterize
cardiovascular deconditioning may become irreversible. A more
immediate question is whether the accelerative stress of reentry
exposure to 1.5 G for up to 20 minutes will pose any hazard to
Shuttle crews, whose times aloft will probably not exceed 2 weeks.
Ultimately, the biomedical feasibility of future manned missions
lasting for a year should be determined as a logical goal in
probing the effects of more prolonged space missions.
Thus, in order to ensure crew safety and effectiveness,
NASA requires more knowledge of (a) the nature and mechanisms of
cardiovascular adaptation and deconditioning that result from the
influence of weightlessness, (b) the occurrence, dimensions, and
practical significance of the possible regressive changes in the
myocardium and other parts of the cardiovascular system, and (c)
the most efficient methods of preventing or treating functional
or organic deterioration of the cardiovascular system, if this
does occur.
NASA requested that the Life Sciences Research Office of
the Federation of American Societies for Experimental Biology
review and evaluate available knowledge and ongoing research and
provide additional scientific input for future research programming
on cardiovascular deconditioning. This has been done with the
assistance of an ad hoc Working Group of outstanding scientists,
supplemented by other prominent investigators, who are identified
in Section VIII.
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II. OBJECTIVES AND SCOPE OF THE STUDY
The objectives of the LSRO study of the problem of cardio-
vascular deconditioning associated with space flight are:
(i) to review extant information on the subject;
(2) to examine NASA's current and projected research
program;
(3) to identify significant gaps, if any, in essential
knowledge;
(4) to formulate suggestions to NASA for future
research; and,
(5) to produce a documented report of the foregoing
items that can be used for NASA program planning for
future research.
The main emphasis in this report, in accordance with
NASA's guidelines, is on the ground-based research and technology
development program on cardiovascular deconditioning. This does
not imply that the LSRO ad hoc Working Group on Cardiovascular
Deconditioning regards the inflight research and development pro-
gram as secondary in importance. In fact, one of the participants
is convinced that the full relevance of ground-based studies rela-
tive to space flight cannot be assessed until information con-
cerning the magnitude and time course of changes in right atrial
pressure in humans during space flight has been obtained.
The main sources of information for the study include (a)
the scientific and technical literature, (b) unpublished data from
the United States and Soviet space programs, (c) the NASA Research
and Technology Objectives and Plans (RTOPs), and (d) Research and
Technology Resumes (RTRs) on cardiovascular deconditioning and
related biomedical problems of space flight. Examples of topics
reviewed in the field of the effects of weightlessness and its
terrestrial analogues on cardiovascular physiology include hemo-
dynamics, cardiovascular adaptation and function, venous compliance,
control mechanisms, orthostatic hypotension, patterns of postflight
readaptation, countermeasures, and methodology for tests, analyses,
and measurements. In addition, the influence of other organ sys-
tems and homeostatic mechanisms on cardiovascular adaptation and
deconditioning is considered where appropriate.
This page was intentionally blank and unnumbered in original printing.
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III. OVERVIEW OF CARDIOVASCULAR DECONDITIONING
This section presents a synopsis of well established
knowledge and certain key issues concerning the responses of the
cardiovascular system to real and simulated weightlessness. Only
a small part of the pertinent literature is cited. Additional
information is available in other reports, compendia, reviews, and
thematic publications, such as: Berry, 1970, 1973; Blomqvist and
Stone, 1983; Bricker, 1979; Busby, 1967; Calvin and Gazenko, 1975;
Gazenko et ai.,1981; Genin and Egorov, 1981; Howard, 1965; Interna-
tional Union of Physiological Sciences, 1979, 1980, 1981; Johnston
and Dietlein, 1977; McCally, 1968; Parrin et al., 1970; Pestov and
Geratewohl, 1975; Roth, 1968; Sandler, 1980; Soffen and Gazenko,
1981; Vasil'yev and Kotovskaya, 1975; Whedon, 1978.
A. DEFINITION
The cardiovascular deconditioning that is associated with
exposure to space flight is said to be an adaptive process that
begins very shortly after entry into orbit. It features a head-
ward shift of blood and body fluids, vascular congestion of the
head and neck, a reduction in total blood volume, and changes in
the physiologic mechanisms that are necessary for maintaining ade-
quate circulation and consciousness while an individual is upright
in the I-G environment (Whedon, 1978). These changes have been
described as adaptive to null gravity, nonimpairing in terms of
crew performance and health, and they stabilize after 4 to 6 weeks
of weightlessness (Dietlein, 1977). Although tolerance to lower
body negative pressure (LBNP) during spaceflight declines, relative
to preflight values, inflight exercise capacity appears to be pre-
served (Genin and Egorov, 1981; Michel et al., 1977), suggesting
that the adaptive changes in the cardiovascular system are appro-
priate to the weightless environment. On return to Earth, however,
when the subject is in the vertical position, orthostatic intoler-
ance occurs, including tachycardia, narrowed pulse pressure, and
hypotension, sometimes resulting in presyncope or frank syncope
(Sandler, 1980). Postflight impairment of locomotion and reduction
of exercise tolerance are also common. These, and other effects on
the cardiovascular system resembling those that are associated with
weightlessness, have been produced as well in ground-based studies
employing bed rest, chair rest, or immersion in water as means of
simulating weightlessness (Sandler, 1980).
Table 1 lists the principal cardiovascular findings of
the nine astronauts in Skylab missions 2, 3, and 4 (lengths of
flight were 28, 59, and 84 days, respectively). Table 2 shows
some of the findings reported by Soviet investigators; it includes
information presented during joint Working Group meetings with
U.S. investigators.
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Table i. Summary of Cardiovascular Observations During Skylab
Missions*
Cardiovascular deconditioning was observed during flight; changes
appeared to be adaptive in nature and tended to stabilize after
4 to 6 weeks.
Cardiovascular changes did not impair crew health or ability to
function effectively in weightless flight.
Inflight lower body negative pressure tests provided a fairly
reliable predictive index of postflight cardiovascular status.
Inflight cardiac electrical activity as measured by vectorcardio-
gram was not significantly altered and remained within physio-
logical limits.
Decreased cardiac output noted in crewmen postflight; thought to
be related to reduced blood volume.
Single episode of significant cardiac arrhythmia noted in one
Skylab 2 crewman during exercise early in mission.
No significant decrement in work capacity or physiologic responses
to exercise during flight.
All crewmen exhibited decrease in work capacity and altered
physiologic responses to exercise after flight including a
decrease in maximal oxygen uptake.
Skylab 3 and 4 crews returned to preflight cardiovascular status
by the fourth or fifth day and the Skylab 2 crew recovered on
the 21st day postflight. Increased exercise by Skylab 3 and 4
crewmen during flight thought to be a factor in improved recovery
rate.
* Modified from Dietlein, 1977.
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Table 2. Cardiovascular E±fects of Long Soviet Space Missions
(96-185 days)*
Increased values inflight
Heart rates moderately greater than preflight values
Ejection times (transient)
Stroke volume and cardiac output, first 2 to 3 weeks
inflight
Cerebral blood flow_, first 3 to 4 months; then return
to preflight values in some, but not all, cosmonauts
Jugular vein pressure
Decreased values inflight
Peripheral resistance
Systolic arterial blood pressure
Venous pressure in legs, average drop 17 mm Hg
Leg volume
Postflight manifestations
Fatigue Decreased stroke volume
Dizziness and ejection time
Sensation of increased Orthostatic intolerance
body weight Impaired locomotion and
Tachycardia coordination
Reduced exercise capacity
* Sources: (i) Soffen and Gazenko, 1981; (2) Gazenko et al.,
1981; (3) Genin and Egorov, 1981.
Estimated from rheographic measurements.
7
B. CARDIOVASCULAR RESPONSES TO WEIGHTLESSNESS AND SIMULATED
WEIGHTLESSNESS
The marked physiologic changes in the cardiovascular system
that occur as the body adapts to weightlessness and its ground-based
analogues have been described in special NASA reports and the open
literature (Bergman et al., 1976; Berry, 1970, 1974; Berry et al.,
1966; Gazenko et al., 1981; Johnson et al., 1973, 1976; Johnston
and Dietlein, 1977; Johnston et al., 1975; Nicogossian et al., 1976;
Rummel et al., 1976; Sandler, 1980). For many cogent reasons, it
has not been possible to conduct exhaustive investigations of cardio-
vascular physiology in humans during space missions, especially in
the first few critical hours and days. Therefore, to supplement
data from space missions, emphasis has been placed on the use of
ground-based models of weightlessness, an approach that permits
flexibility in design and control of experiments (Nixon et al.,
1979; Sandler, 1980).
Studies on experimental animals in space have not added
significantly to the understanding of cardiovascular deconditioning.
However, some limited but useful data were acquired from dogs (USSR)
and from monkeys and chimpanzees (USA) prior to human spaceflight,
and studies of animals in space may ultimately prove to be the only
feasible means of acquiring certain types of data on cardiovascular
deconditioning and other biomedical problems of spaceflight
(Sandier, 1980).
Cardiovascular responses to weightlessness
Immediately after entering orbital flight, the body
begins to adapt to the weightless environment. There is a shift
of possibly as much as 2 liters of blood and interstitial fluid
from the lower to the upper half of the body, with the major por-
tion of the shifted volume entering the intrathoracic organs,
including the heart chambers and pulmonary vessels. Soviet scien-
tists have reported a sustained increase in jugular venous pres-
sure (Yegorov, 1981). In the lower extremities, they observed a
reduction of venous pressure and, by mission days i0-ii, an aver-
age volume decline of 10%. Astronauts notice fullness in the
head, stuffy noses, nasal voices, and slender legs, which they
have termed "puffy faces and birdlegs" (Johnston and Dietlein,
1974, 1977; Money, 1981).
Mean resting inflight values of heart rate and of the
arterial systolic and pulse pressures tend to be greater while
arterial diastolic pressures tend to be less than the preflight
values (Sandler, 1980). It is postulated, but not documented in
flight, that the large, headward shift of blood volume rapidly
induces a diuresis in response to increased right atrial pressure.
In turn, this leads to a reduction in plasma volume (Lamb, 1966),
which has been described as an actual and a functional hypovolemia,
as reflected by postflight orthostatic intolerance and impaired
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exercise capacity (Blomqvist and Stone, 1983). A negative fluid
balance with a reduction in plasma volume may also result from
decreased fluid intake during the initial hours or days of a space
mission. Grigoriev (1981) emphasized that the question of diuresis
early in orbital flight will remain uncertain until it is measured
directly.
With few exceptions, electrocardiographic changes observed
during space flight have been unremarkable (Dietlein, 1977; Genin
and Egorov, 1981; Sandler, 1980; Smith et al., 1977) and were
judged to be within normal physiologic limits (Dietlein, 1977).
Skylab data showed increases in the magnitude of the maximum QRS
and T vectors and an increase in the PR interval (Smith et al.,
1977). Sporadic ventricular ectopy occurred during the Skylab mis-
sions. Slight but significant increases in the amplitudes of T and
U waves have been reported in bed-rested subjects after 2 to 3
weeks (Sandler, 1980).
The average loss of weight in nine astronauts during the
three manned Skylab missions was approximately 3 kg (Thornton and
Ord, 1976). Factors that are presumably responsible for the loss
of weight include negative fluid balance in response to fluid
shifts and/or inadequate intake, skeletal muscle atrophy, and loss
of body fat as a result of restricted caloric intake (Leach et al.,
1979). Nixon et al. (1979) estimated that about one-half the loss
of weight occurs within 3 days of the start of the mission and most
probably results from a loss of interstitial fluid.
Yegorov (1981) reported the following responses to LBNP
in cosmonauts during long-term missions: heart rate, peripheral
vascular resistance, and the arterial pulse wave velocity increased,
while stroke volume and cardiac output fell. The increase in calf
volume in response to LBNP during flight was greater than the
analogous response to simulated weightlessness.
After return to Earth, all astronauts and cosmonauts have
exhibited some degree of cardiovascular deconditioning, regardless
of mission length. It is characterized by inappropriate heart
rate and blood pressure responses to the upright posture, head-up
tilting, or LBNP. The responses include tachycardia, a drop in
systolic blood pressure, and narrowing of pulse pressure. Fatigue,
presyncopal signs and symptoms, and reduced exercise tolerance have
been documented, as well as impaired locomotion. These manifesta-
tions of the altered state of the cardiovascular system and its
controls have persisted for a few days to approximately 1 month
postflight; however, the usual duration has been from 2 to 4 days.
Echocardiographic measurements of cosmonauts after long space
missions show a mean 25% decrease in left ventricular volume
(Sandler,. 1982a); however, there is no firm evidence of an actual
loss of cardiac muscle.
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Figures i and 2 are conceptual diagrams of the responses
of the cardiovascular and related systems to weightlessness or its
ground-based analogues.
Cardiovascular responses to simulated weightlessness
The effects of bed rest and other ground-based technics
of simulating weightlessness are very similar to those outlined
above for actual weightlessness. Despite universal acknowledgment
that the ground-based models cannot be equated to the zero-gravity
environment, they do approximate certain features of weightlessness
and do permit controlled biomedical studies and tests of possible
countermeasures (Nixon et al., 1979; Sandler, 1980).
Important differences in responses to ground-based models
and the actual zero-G environment occur because the effects of
gravity on the spatial distribution of pulmonary blood and gas
volumes and flows cannot be avoided by either bed rest or water
immersion: (i) the lungs are anatomically fragile; (2) the pul-
monary vascular bed is the most compliant segment of the vascular
system; and (3) because of the large differences between the
specific gravity of the respiratory gases and the blood and tissues
surrounding the alveoli and airways, pulmonary function is highly
susceptible to changes in the direction and magnitude of the
gravitoinertial force environment (Wood et al., 1963a). In addition,
while the bed rest model reduces dependent systemic venous pooling,
it cannot entirely eliminate it**
Blomqvist and Stone (1983) note that a marked change in the
hydrostatic conditions that prevail in man in the upright position
on Earth results when subjects are exposed either to experimental
bed rest, to head-out immersion in water, or to actual weightless-
ness. A redistribution of intravascular and interstitial fluid from
the lower to the upper half of the body is the main, acute, hemo-
dynamic effect. The mechanisms for adaptation to the relocated
fluids and altered intravascular pressures associated with bed rest,
immersion, or zero-G are thought to be basically similar. Hypo-
volemia, reduced stroke volume and cardiac output, orthostatic
intolerance, and decreased exercise capacity are the common results
of exposure to real and simulated weightlessness (Blomqvist and
Stone, 1983).*
The various physiologic mechanisms respond more rapidly
to head-out immersion than to bed rest. Nevertheless, bed rest
has been used more extensively to simulate weightlessness because
of its relative simplicity and freedom from immersion-induced
* One member of the ad hoc Working Group suggested that the third
and fourth paragraphs require altered emphasis (see Appendix,
p.63-66).
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hydrostatic forces. Such forces act on the body to create a state
of negative pressure breathing and, in turn, a shift of blood into
the intrathoracic circulation (Sandler, 1980). Recent studies sug-
gest that a head-down tilt of about 5° simulates the agravic qua!-
ities of weightlessness more closely than the supine position
(Kakurin et al. , 1976; Nixon et al. , 1979). However, not all
investigators concur in this conclusion (Hyatt and West, 1976).
Most cardiovascular responses to real and simulated weight-
lessness appear to be similar. However, some significant differ-
ences have been observed or postulated, such as the volume response
of the lower extremities during LBNP. The extraordinary inflight
pooling of blood in the legs induced by LBNP has been documented in
the Skylab missions (Johnson et al. , 1977) but it has not occurred
in most bed rest studies of the changes in leg volumes during LBNP.
However, interpretation of this difference should take into account
the eflect of differences in instrumentation used inflight versus
that used in the ground-based studies. Also, a dramatic reduction
of lower limb girth develops during space flight. Nixon et al.
(1979) studied the cardiovascular changes in normal human subjects
that occur during the first 24 hours of 5° head-down tilt bed
rest. They recorded a mean total reduction of 0.9 liters in the
volume of both legs, which, according to the authors, closely
matches the initial, rapid phase changes observed during the
Skylab studies.
Subjects experience a marked natriuresis and water diuresis
during the initial hours of water immersion to the neck and during
the first day or two of bed rest (Epstein, 1978). In addition, a
kaliuresis of shorter duration than the natriuresis occurs in water
immersion. Whether these changes occur in weightlessness is not
known, but they have been postulated (Berry, 1973).
As a possible countermeasure against cardiovascular decon-
ditioning, exercise has generally failed to prevent the orthostatic
intolerance that results from simulated or actual weightlessness.
However, postflight recovery time of the crews of Skylab missions
3 and 4 (4-5 days) was significantly less than that of Skylab 2
(21 days). The use of vigorous exercise by the crews of Skylab 3
and 4 may have accounted for the difference (Dietlein, 1977).
While certain evidence suggests that central venous pres-
sure (CVP) in human subjects remains elevated throughout long space
missions (Yegorov, 1981), results of bed rest studies suggest either
that CVP does not change or that it increases transiently. After
initiation of 5° head-down tilt, CVP in human subjects increased
within 30 minutes to peak values and returned to near control values
within 90 minutes (Nixon et al., 1979). However, in studies of
human volunteers with indwelling venous catheters, there was no
increase in CVP during 7 days of 5° head-down tilt (Katkov, 1981).
The anatomical zero reference point for measuring central venous
pressures is treated on page 27.
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Tables 3 and 4 list the generally recognized, prominent
cardiovascular and other physiologic changes that have been
reported from spaceflight and simulation studies. They include
known and postulated mechanisms, and identify associated unan-
swered questions and problems. Firmly established mechanisms for
the listed responses either do not exist or fall short of providing
complete explanation. This lack of definitive information results
in a relatively large listing of hypotheses and concepts, many of
which are under investigation.
C. COUNTERMEAS URES
Attempts to prevent or control cardiovascular decondition-
ing have involved inflight, reentry, and postflight measures. Also,
various interventions have been tested during and after bed rest and
other ground-based analogues of weightlessness. These measures have
included inflight exercises and LBNP, venous occlusion, pre-reentry
fluid and electrolyte replacement, use of anti-G suits during and
following reentry, and postflight supportive measures (Sandler,
1980). In addition, drugs and hormones have been tested experi-
mentally. Among the more promising countermeasures that have been
evaluated in manned space flight are active exercise, hydrostatic
stressing of the lower half of the body by repetitive LBNP, oral
fluid and electrolyte replacement before reentry, and the use
of anti-G posture and anti-G suits during reentry (Johnston and
Dietlein, 1977; Sandler, 1980; Yegorov, 1981).
Artificial gravity used during the flight of the Kosmos
936 biosatellite appeared to protect rats against certain musculo-
skeletal degenerative effects (Oganov, 1981; Simmons, 1981). Avail-
able evidence from these and other biosatellite experiments is in-
sufficient to establish whether degenerativeeffects occur in the
rat myocardium during zero-G exposures of approximately 3 weeks.
No gross or histologic (by light microscopy) abnormalities of
the myocardia of such animals have been detected (Gazenko et al.,
1980). However, myocardial phosphorylases a and b were increased
postflight, and a mean reduction of 44% in myosin ATPase activity
was found. Baransky et al. (1980) reported changes in the structure
of mitochondria, smooth endoplasmic reticulum, and glycogen content
of cardiac muscle cells of rats exposed either to zero-G or to 1.0 G
produced by an onboard centrifuge during the 21-day flight of Kosmos
936. Thus, artificial gravity did not prevent the observed ultra-
structural changes.
Expert opinion is divided about the extent of protection
offered by such measures as vigorous, regularly scheduled exercise,
repeated LBNP, and pre-reentry fluid and electrolyte replacement
(Dietlein, 1977; Sandler, 1980; Thornton, 1981; Yegorov, 1981).
From their experience with long-term manned flights, Soviet invest-
igators are sufficiently convinced of the efficacy of such measures
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Table 3. Mechanisms of lluman Cardiovascular Adaptation to Real or Simulated Weightlessness
Observed Responses* Known Mechanisms Postulated Mechanisms Essential Missing Information
I. Rapid shift of Intravas- Absence of all hydrostatic Altered vascular compliance and/or Acute and chronic effects on:
cular and interstitial fluid (gravitational) pressure capacity; altered cardiac output right atrial pressures; pulmonary
to upper'half of body gradients and distribution of blood flow; blood and gas volumes and flows;
hormonal and renal changes in left atrial pressures; shapes and
chronic adaptation pressure-volume dynamics of cardiac
chambers; shape and position of
diaphragm; splanchnlc and cerebral
blood volumes, pressures, and flow
distribution; pressure and volume
receptors.
2. Echocardlographle evidence llypovolemla Reduced peripheral resistance, Whether any loss of myocardial
of a mean 25% decrease in left diastolic and arterial blood mass occurs
ventricular volume after long pressure; net decrease In
missions cardiac workload
3. DluresIs and natriuresls Suppression of ADM release via Gauer-}lenry reflex In weightless- Whether diuresis and natrluresls
during Initial 24-48 h stimulation of atrial pressure ness7 Changes in pressure and occur in first 24-48 h of 0-G:
receptors (Immersion; bed rest) neurohumoral content of eerebro- whether physiologically significant
spinal fluid (CSF)? changes In CSF pressure and neuro-
humoral content occur; effects on
ADH and aldosteroneO1
4. Hypovolemia of 300-500 ml Diuresfs and Increased trans- Headward fluid shift activates Whether hypovolemfa occurs Independ-
develops within 24-48 h capillary fluid shift from volume or low-pressure receptors; ently of volume or low-pressure receptor
lower body tissue space inactivity; imbalance of fluid In- function. Whether mental stress early
take and output In mission affects fluid shlft and diu-
retie mechanisms vla sympatho-renal or
other neuroendocrine pathway; right
atrial pressures; pulmonary blood flow
and volume; left atrial pressures;
position, shape, and pressure-volume
dynamics of cardiac chambers; cardiac
output and magnitude of sympathetic
activity; systemic vascular
resistance.
5. Relative to preflight values, Stimulation of volume and low- A widened pulse pressure wIth an Status of cardiovascular reflexes in
Skylab fnfllght mean resting pressure receptors by relative Increased heart rate suggests an real and simulated weightlessness
heart rates, systolic, and hypervolemla in upper half of increased cardiac output and re-
pulse pressures increased; body duced peripheral resistance
diastolic and mean arterial
pressures decreased
* The most frequently, but not Invariably, reported human adaptive responses to real or simulated weightlessness. Postflight and
post-simulatlon effects are listed In Table 4.
Table 3. (contlnoed)
Observed Responses Known Mechanisms Postulated Mechanisms Essential Missing Information
6. Increased left ventrlcular Increased EDV with unchanged Reduced contractility of heart, but Accurate, more complete data
end-diastollc and end-systollc stroke volume suggests larger increased systolic blood pressure
volume in first 24 h of 5° ESV also suggests an increased after
head-down tilt; stroke volume load
and cardiac output unchanged
7. Reference baseline values, Hypovolemia and lower arterial Increased ejection fraction and Inconsistencies in results by
decreased LVED volume and pressure load coupled with relative tachycardla offset de- different investigators should
\stroke volume wlth unchanged tachycardla creased LVED volume be resolved; more accurate and
or reduced cardiac output more complete data
after 2 wk bed rest; more
pronounced in females
8. Soviets re|tort increased Increased filling pressure from Reduced peripheral vascular resist- Same as In item #I, Including end-
stroke volume and cardiac headward shift of body fluids; ance resulting in decreased cardiac diastolic and end-systolic volumes;
output, peak values at 6-9 Starling's mechanism via greater workload accurate cardiac output and vascular
d of head-down tilt and filling of heart ventricles pressure data
first 2-3 wk inflight
9. Soviets found decreased Increased stimuli to low- Stimulation of mechanoreceptors Same as in Item #8; distribution of
_--A infllght peripheral vascular pressure mechanoreceptors; as a result of altered Intra- change in vascular resistance in
resistance and arterial increased pulse pressure causes vascular pressures; altered different body regions
blood pressure greater discharge of high- peripheral sympathetic function;
pressure receptors Impalred noreplnephrine release
I0. Transient elevation (+2.7 Cephalad shift in clrcu- Reduced plasma volume; stress Same as in item #I; accurate data on
cm I120) central venous pres- fating blood volume and relaxation (or creep) of the CVP mandatory for understanding
sure in 5° head-down tilt extracellular fluids; capacity vessels mechanisms of cardiovascular adapta-
(total duration of effect 90 natrluresis and dluresls tlon; variance in data needs
mln); recent USSR data do not resolution
confirm
ll. Soviets report sustained tlemodynamtc effect of Inactivity; relative disuse of Same as in item #1; gradual trend to
increase in Jugular vein cephalad shift of body lower extremities; loss of muscle normal cerebral flow in some cosmo-
pressure lnflight; also fluids; absence of verti- pump nauts needs confirmation; whether CVP
elevated cerebral blood cal gradient in vascular is chronically elevated; complete
flow first 3-4 mo inflight pressures at zero-G picture of redistributed blood flow
estimated by rheography and effects thereof
Table 3. (continued)
Observed Responses Known Mechanisms Postulated Mechanisms Essential Missing Information
12. Relative to Inflight resting Reflex C-V responses to Reduced arterial mechano- More accurate and complete
values, Infllght lower body reduced blood volume; receptor activity; increased vaso- information is needed;
negative pressure (LBNP) tests interstitial fluid in legs motor center activity; enhanced confirmation of infllght vs
showed increases in: heart decreased; lower vascular adrenerglc activity; decreased preflight LBNP data; sympathetic
rate, peripheral resistance, tone; impaired venous return responsiveness of vascular smooth activity; systemic vascular capacity;
mean arterial pressure, including muscle pump muscle to adrenergfc neural activity; accurate data on magnitude of fluid
diastolic pressure, pulse wave "altered venous capacitance and/or volume change trapped in lower body
propagation, and blood pooling capacity; decreased skeletal muscle during LBNP; status of high- and
in legs*; and decreases in tone; large displacement of blood to low-pressure cardiovascular reflex
systolic and pulse pressures, lower half of body relative to Earth systems; explanation for apparent
stroke volume and cardiac output conditions; increased distensibility paradox of decreased peripheral
of lower llmb veins vascular receptor activity during
increased arterial blood pressure
13. Altered vascular compliance Passive stretch and/or increased Does weightlessness induce transient
and capacity in such responses distensibility of veins; altered or sustained changes in vascular com-
as high degree of blood pooling peripheral sympathetic function; pllance and capacity, atrophy of vascu-
in legs during infllght LBNP reduced vascular tone, transmural cular musculature, vascular remodeling?
pressure; collapsed veins Distinct roles of high- and low-pressure
receptor reflexes? Separate information
_.A on vessels in upper and lower halves of
"q the body
14. Decreased red blood cell Changes in erythrocyte shape? Is this effect fully reversible in long-
mass proportional to hypo- Reduced release of erythropoletln term flights? Is loss independent of O-G?
volemla associated with reduced hemoglobin Relationship between loss and observed
concentrations and oxygen delivery changes in red cell shape? What is basic
to the kidney? mechanism?
15. Near 10% decreased Infllght Cephalad shift of diaphragm? The practical significance of the observed
vital capacity, Skylab 3 pilot Redistribution of body fluids to changes; magnitudes and spatial distribution
and all crew of Skylab 4 thorax? Direct result of 5 psla of pulmonary blood sod gas volumes and flows;
cabin pressure? shape and position of diaphragm
16. Decreased urinary norepl- Changed functional state of sym- Control mechanisms; resolution of Incon-
nephrlne excretion in bed rest pathetic nervous system? Impaired slstencfes in research results; effect of
studies; however not all noreplnephrlne release or uptake tension (mental stress) on this phenomenon
studies confirm into granules?
* Relatlve to preflight values
Table 3. (continued)
Observed Responses Known Mechanisms Postulated Mechanisms Essential Missing Information
17. Skylab infllght hormones: Increased Intracranlal pressure Resolve apparent paradox of Increased
plasma cortlsol, angiotensln I alters control and production of sodium excretion in presence of high
increased or normal; plasma CNS regulatory hormones; cephalad plasma aldosterone; confirm head-down
ACTII, insulin, aldosterone shift of blood and Interstitial bed rest as model of O-G for study of
decreased; urinary cortisol, fluid causes multiple hemodynamic hormone and electrolyte responses;
aldosterone, total 17-KS In" changes that influence homeo- assess relative influence of O-G vs
creased; trend toward decreased stasis of water and electrolyte other environmental and operational
urinary ADH, epinephrine and metabollsm factors
noreplnephrlne
18. Skylab Infllght electrolytes: Increased cardiac output or some Confirm increased plasma potassium and
plasma sodium decreased; urinary endocrine change acting on the kidney increased urinary potassium excretion;
sodium increased; trend toward source of these changes In potassium
increased plasma potassium; turnover; extend knowledge of endocrine
urinary potassium increased changes
OO
Table 4. Mechanisms of Postfllght and Post-slmulatlon Orthostatlc Intolerance
Observed Responses * Known Mechanisms Postulated Mechanisms Essential Missing Information
1. Tachycardia with body Ilypovolemia; decreased Loss of vascular and muscular tone, Nature and extent of deterioration of
upright _r with head-up stroke volume especially lower extremities; abnormal reflex mechanisms responsible for car-
passive tilt; postural reflex cardiovascular regulation; diovascular function; wily is degree of
hypotension, sometimes Increased distensibility of leg veins; C-V dysfunction greater than expected
with presyncope or syncope: decreased tissue pressure in lower from amount of hypovolemfa? Effect of
LBNP tolerance reduced post- extremities; reduced baroreceptor O-G on (I) sensitivity, numbers, dis-
flight and after simulation sensitivity; increased vagal discharge trlbutlon of C-V mechanoreceptors, (2)
plus existing sympathetic response to thermoregulatlon; (3) right atrial
upright tilt or standing; decreased pressure; (4) pulmonary blood and gas
cardiac work capacity; impaired re- pressures and flows; (5) left atrial
lease of endogenous noreplnephrlne pressure; (6) functional dynamics of
cardiac chambers
2. Marked reduction in maximal Decreased stroke volume Decreased oxygen uptake, ventilatory Nature and extent of effects on reflex
and submaxlmal work capacity, volume, maximal heart rate, LVED mechanisms that control cardiopulmonary
upright and supine volume, and cardiac filling pressures function; effects on C-V mechanoreeeptors;
and output; physical inactivity; re- functional dynamics of cardiac chambers;
duced muscle strength, tone, blood effect of exercise Infllght and during
pumping action; decreased heart size simulation
and cardiac work capacity
iO 3. No increase In pooling of Difference in responses suggests a Same as in #I above
blood in legs of most bed- a factor in ground-based models that
rested subjects during LBNP sustains vascular and skeletal muscle
tests; marked increase infllght "tone"; most likely the hydrostatic
pressure gradients of gravity. Peri-
odic turning of subject from prone to
supine also probably affects results.
4. Tolerance for acceleration of llypovolemfa and decreased interstitial Same as in #2 above
+2.5C z (eyeballs down) declined pressure in lower extremltles
In 20% of centrlfuge-experienced
subjects after 24 h bed rest;
tolerance less for inexperienced
subjects
* The most frequently reported responses; however, some results are inconsistent with tileresponses listed above.
that they would consider their omission during long-term missions
as unethical (Soffen and Gazenko, 1981; Yegorov, 1981). NASA sci-
entists tentatively concluded that, compared with the results of
Skylab 2, the relatively superior pattern of postflight cardiovas-
cular readaptation of the crews of Skylabs 3 and 4 probably
resulted from the vigorous exercise program during the latter two
missions (Dietlein, 1977). However, lack of reliability, incom-
plete protection or impracticality for space flight use have
caused some investigators to regard such countermeasures as margin-
ally effective or ineffective in preventing cardiovascular decon-
ditioning, particularly the orthostatic intolerance, associazed
with weightlessness and its ground-based models (Johnson et al.,
1977; Sandler, 1980).
Another approach to the subject of countermeasures
involves the apparent resistance of some space flyers to cardio-
vascular deconditioning as measured by the time required postflight
to return to preflight physiologic status. It may be possible to
correlate certain physiologic or behavioral characteristics of such
individuals with their partial resistance to cardiovascular
deconditioning.
In spite of variable and sometimes contradictory results
obtained during studies of countermeasures, certain approaches
have appeared promising enough to warrant further research and
development. Among these inflight countermeasures are dynamic
exercise, static exercise (Stremel et al., 1976), centrifugation
(Kotovskaya et al., 1980; Shulzhenko et al., 1976; White et al.,
1966), prolonged LBNP stressing (4 h/d) combined with oral replace-
ment of fluids (Hyatt and West, 1977), and the use of anti-G suits
or leotards (Berry, 1975; Buyanov et al. , 1967; Hordinsky, 1977;
McC_ally et al. , 1968).
D. RELATED FACTORS AND PHYSIOLOGIC FUNCTIONS
Reports of numerous investigations have suggested that
the mechanisms of response of the cardiovascular system to weight-
lessness are multiple and not necessarily restricted to the attend-
ant major fluid shift from the lower to the upper half of the body.
In addition to weightlessness, other characteristics of the space-
flight environment should probably be taken into account such as
the behavioral and physiologic effects of confinement, isolation,
apprehension, monotony, and reduction in social contacts (Kozerenko
et al. , 1981).
Exposure to weightlessness influences fluid and electro-
lyte balance, metabolism of minerals and other nutrients, and
certain endocrine functions. Thus, many variables are involved in
assessing cardiovascular changes during complex interactions among
the diverse organ systems and functions of the weightless body
2O
(Pestov and Geratewohl, 1975). Consequently, it would be appro-
priate to conduct further studies of the sequence and interdepend-
ence of changes in cardiovascular, renal, endocrine, and sensory
functions associated with weightlessness or its ground-based
analogues (Bju'rstedt, 1980; Whedon, 1978).
Table 5 lists responses that have been noted in physio-
logic systems and functions other than the cardiovascular system,
per se. Whether these observed phenomena have a direct relation-
ship to cardiovascular deconditioning is not established. The
NASA research programs on fluid and electrolyte metabolism, renal
function, musculoskeletal integrity, and vestibular function are
aimed at resolving problems in these specific areas. Clearly,
advances in understanding these responses may also extend knowl-
edge about their relationships to cardiovascular deconditioning.
21
Table 5. Non-Cardiovascular Responses of Organs, Organ Systems,
and Physiologic Functions Associated with Spaceflight or Ground-
Based Simulation*
Vestibular disturbances and space motion sickness
Loss of red cell mass
Weight loss (probably from combination of metabolic, body
fluid, and muscle mass losses)
Moderate loss of skeletal muscle mass
Moderate losses of calcium (skeletal) and phosphorus and
nitrogen (skeletal muscle)
Inflight decreases in ADH secretion (except Skylab 2)
Inflight increases in aldosterone and cortisol secretion
Inflight increases in urinary excretion of sodium and potassium
Unimpaired renal function; elevated renal blood flow in bed
rest
Reduced postflight exercise tolerance which may reflect musculo-
skeletal, hormonal, and nervous system changes as well as
changes in the cardiovascular system; for example:
Possible change in the functional state of the
peripheral sympathetic nervous system in terms
of vascular resistance and venous tone; possible
impairment of norepinephrine release or uptake
into granules
* Sources: Dietlein, 1977; Sandler, 1980; Soffen and Gazenko, 1981.
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IV. NASA'S PROGRAM OF GROUND-BASED RESEARCH
IN CARDIOVASCULAR DECONDITIONING
The ad hoc _orking Group examined the current NASA pro-
gram of ground-based research in cardiovascular deconditioning to
form an opinion of its potential to meet NASA's needs. The main
sources of information were the NASA Research and Technology Objec-
tives and Plans (RTOPs) and Research and Technology Resumes (RTRs)
for Fiscal Year 1983, information presented by NASA scientists during
the meeting of the ad hoc Working Group on July 6-7, 1982, and both
published and unpublished information on the cardiovascular effects
of space flight and its ground-based analogues.
In general, the RTOPs for the cardiovascular decondi-
tioning program appear adequate in scope and content. The stated
objectives for elucidation of the mechanisms of cardiovascular
deconditioning are well conceived and scientifically sound. The
current NASA program supports some degree of effort in most of the
research recommended in the reports of the Space Science Board Com-
mittee on Space Biology and Medicine (Bricker, 1979) and the NASA
Life Sciences Advisory Committee report of 1978 (Whedon, 1978).
The extant and planned research tasks documented for
FY 1983 were compared with the Technical Objectives. Of the 17
tasks formally documented in the RTRs, ii are devoted mainly to
investigations of the underlying mechanisms of cardiovascular
deconditioning; one to development and test of countermeasures,
and five to development, test, and acquisition of improved method-
ology, equipment, and facilities. In connection with its basic
research on cardiovascular deconditioning, the Ames Research Center
(ARC) program includes a small amount of countermeasures testing
with rhesus monkeys (anti-G suits; abdominal pressure) as well as
some equipment and methodology development.
The ad hoc Working Group is aware of the practical diffi-
culty faced by temporary scientific advisory bodies of quickly
obtaining a complete picture of extensive research and development
programs. Moreover, it recognizes that the NASA research program
in cardiovascular deconditioning is dynamic, because the tasks are
adjusted periodically as new research is begun and other tasks are
completed. In addition, the ad hoc Working Group realizes that
the program is somewhat hindered by fiscal limitations and by lack
of awareness of and interest in NASA's biomedical problems by a
large part of the potentially-participating scientific community.
These considerations notwithstanding, the Working Group regards
the program as generally appropriate, but perhaps not adequate in
terms of the level of effort needed to meet the objectives listed
in the RTOPs. The total number of research groups working on
cardiovascular deconditioning is such that it will probably take
many years to reach satisfactory solutions, particularly in
working out those essential mechanisms that may lead to sound
methods of intervention.
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The difficulties of forecasting breakthroughs in basic
research on the complex mechanisms of cardiovascular deconditioning
make it infeasible to estimate a realistic schedule for resolution
of key problems. Thus, the time for acquisition of necessary data
on basic mechanisms is long-term, or probably more than 5 years.
However, it is feasible to predict schedules of progress in
such applied areas as improved countermeasures, improved test
methodology, and associated equipment and facilities. The long-
term nature of the basic researc_ program may be acceptable to
NASA planners in view of the absence of any identified, permanent,
incapacitating cardiovascular effects of manned space missions to
date.
The NASA research program reflects the current state-of-
the-art. However, the state must be improved considerably. As
is indicated in Section V, advances are needed in the precise
understanding of the characteristics and mechanisms of cardiovas-
cular responses such as: (i) the changes in right atrial pressure
associated with cephalad blood volume shifts, (2) the magnitudes
and spatial distributions of pulmonary blood and gas volumes and
flows, (3) the associated changes in left atrial pressures, (4)
position, shape, and pressure-volume dynamics of the cardiac
chambers, (5) possible subacute and chronic changes in myocardial
mass, (6) shape and position of the diaphragm and associated lung
volumes, (7) magnitudes and spatial distributions of splanchnic
and cerebral blood volumes and flows, (8) possible effects on
(a) circulatory pressure and volume receptors, and (b) venous
"tone" and capacitance, and (9) possible histopathologic and
biochemical changes in the myocardium after exposures to real
or simulated weightlessness. Equally important will be the
development and verification of better ground-based models for
simulating the flight environment of the astronauts and the
development of more effective and practical countermeasures.
Inasmuch as an accurate understanding of underlying bio-
logic mechanisms of cardiovascular deconditioning is ultimately
essential to practical advances in spacecrew protection and welfare,
and in view of the long-term nature of such investigations, it is
not surprising that the research suggested by the ad hoc Working
Group in this report resembles in many respects that of previous
advisory groups.
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V. OBSERVATIONS OF THE AD HOC WORKING GROUP
ON CARDIOVASCULAR DECONDITIONING
Among NASA's dominant current and future goals are the
productive operation of the Shuttle-based Space Transportation
System, and the development of a manned space station in low Earth
orbit (1980s). Evaluation of the biomedical research program in
cardiovascular deconditioning should take into account a proper
balance between basic and applied research in order to assure prog-
ress in the primary missions of the agency. Although the number
of persons who have participated in space flights is limited, the
absence of serious adverse biomedical effects is encouraging: no
mission has been reported to have been compromised by biomedical
events, and all observed biomedical effects appear reversible.
Thus, space mission programmers feel reasonably confident about
the ability of carefully selected and trained spacecrews to carry
out orbital missions of at least 6 months' duration.
Nevertheless, significant questions arise concerning the
human adaptability to and recovery from the effects of more pro-
longed missions and concerning the ability of certain future space
flyers to cope with weightlessness and other factors in the space-
flight environment. For example, the scientists and technicians
who will participate in the forthcoming missions of the Shuttle-
Spacelab will not all be experienced test pilots who will meet the
most stringent medical standards for flying. Instead, they will
tend to be older and will more nearly represent the average popula-
tion in terms of physical condition and prior aerospace experience
(Sandler, 1981).
In view of uncertainties about human tolerance for more
prolonged missions than heretofore, whether the adaptive changes
in the cardiovascular system are truly reversible after more pro-
longed exposure, and whether "ordinary" human beings can adapt and
function in such programs as Shuttle-Spacelab, a carefully drawn
research program in cardiovascular deconditioning seems highlyjustified.
A. H EMODYNAMIC FACTORS
i. Current Status
It is an accepted fact that a cephalad shift of
blood volume occurs at the onset of exposure to weightlessness.
Most experts agree that this initial, major hemodynamic effect is
probably responsible for the cardiovascular deconditioning which
follows. Current views of the probable mechanisms involved in the
cardiovascular deconditioning associated with space flight are
summarized in Section III, in particular in Table 3.
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Knowledge of the extent and nature of cardiovascular sys-
tem changes during the first day or two of spaceflight is scanty,
and only a few reports of such temporal data from simulation studies
in human subjects have appeared (Blomqvist et al., 1980, 1981; Nixon
et al., 1979). Information is incomplete about the regional anatom-
ical and temporal aspects of redistribution of blood flow during
weightlessness and about the significance of such redistribution
on cardiovascular adaptation and deconditioning.
In this report, the terms venous compliance and venous
capacitance are synonymous and are defined as representing the vol-
ume change per unit pressure change (Gow, 1980; Shoukas and Sagawa,
1971). Vascular capacity refers to the volume of blood contained
in the capacitance vessels at a given pressure (Folkow and Neil,
1971).
The complex role of the veins in cardiovascular homeostasis
has been reviewed by Shepherd and Vanhoutte (1975), Hainsworth and
Linden (1979) and Rothe (1983). From animal studies, it appears that
non-splanchnic venous activity is much less responsive to cardio-
vascular reflexes than are splanchnic venous responses (Brunner
et al., 1981; Shepherd and Vanhoutte, 1975; Rothe, 1983). Further-
more, compensatory venous responses appear to be predominantly from
changes in unstressed volume rather than from changes in compliance.
Therefore, estimates of systemic vascular capacitance changes, based
on studies of forearm or leg venous compliance in people, may be
either grossly underestimated or misleading.
There is a limited understanding of the degree, temporal
development, and duration of changes in pressure and composition
of the cerebrospinal fluid (CSF) associated with weightlessness
and its analogues. The operating point of the heart relative
to the Frank-Starling mechanism is not well defined. Finally,
although data from humans during spaceflight do not suggest a
respiratory hazard or irreversible cardiac changes, information
is insufficient to rule out potential pathologic consequences of
altered cardiopulmonary pressures during prolonged exposure to
zero-G.
2. Critical Questions
The Working Group raised the question about whether
the heart or the vascular system is mainly responsible for the
adaptive and "deconditioned" responses of the cardiovascular sys-
tem. They discussed the related question concerning possible sig-
nificant changes in venous compliance and capacity and the loca-
tion, nature, extent, and dependence upon the cephalad shift of
blood volume of such changes in the venous system. Another related
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question was whether significant changes of intraabdominal pres-
sure occur during weightlessness, and the possible influence of
abdominal muscle tone on such pressures.
The participants considered whether disappearance of grav-
itational pressure gradients in the lungs during zero-G may play a
role in the adaptive or deconditioning process, and whether such
gradients may influence the adjustments of the cardiovascular sys-
tem to prolonged bed rest. The hemodynamic significance of the
absence of pressure gradients within the thorax may be of equiva-
lent or even greater importance than is the absence of these
gradients in the lower extremities. The thoracic blood volume con-
siderably exceeds that in the legs, and the absence in the zero-G
environment of the 15-20 cm vertical pressure gradients in the
very compliant pulmonary vasculature, which are normally present
at I-G irrespective of body position, must have significant effects
on the spatial distribution of pulmonary blood and gas volumes and
flows and consequently on right and, particularly, left atrial
filling pressures in the agravic environment.
A basic question that remains unanswered is whether the
physical inactivity imposed by the limitations of the spacecraft
is more or less important than the headward shift of blood and
fluids in the genesis of the deconditioning response. Although
some evidence suggests that a schedule of vigorous inflight exer-
cises moderates the deconditioning, the issue is unclear. Two
additional questions considered to be significant are: how close
is the operating point of the astronaut's heart to the plateau of
the Frank-Starling curve during various phases and activities of
space flight, and what is known of the exact triggering mechanism
that leads to syncope?
3. Suggested Research
It is necessary to assess cardiovascular function
and autonomic control at various stages of actual or simulated
weightlessness. Multiple endpoints of cardiovascular function
should be measured, such as central venous pressures, heart rate,
ECG, systolic and diastolic arterial pressures, cardiac output,
pressure-volume dynamics of the cardiac chambers, the magnitudes
and spatial distributions of pulmonary blood and gas volumes and
flows. Vital capacity, residual lung volume, and pulmonary dif-
fusing capacity should also be measured, as should intracardiac
and vascular transmural pressures.
Very small (1-5 cm water) variations in right and left
atrial pressures may be of considerable hemodynamic significance.
The pathophysiologic significance of venous pressure values is
difficult to evaluate unless the anatomic zero reference point for
reported values is accurately specified. The midpoint of the
dorsal-ventral dimension of the thorax measured at the junction of
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the second intercostal space at the sternum is generally accepted
as the mid-chest level and as a suitable reference point for mea-
surement of circulatory pressures (Greenleaf et al., 1974).
Another useful endpoint for assessing cardiac fuction is
the E-max approach of Suga and Sagawa for estimating contractility
(Sagawa, 1981), if adequate estimates of ventricular pressures and
volumes become available. This concept of E-max has been used
experimentally by Nixon et al. (1982). With regard to the oper-
ating point of the heart relative to the Frank-Starling curve, an
investigative approach might involve the measurement of cardiac
output while the central venous pressure is raised or lowered by
applying positive or negative pressure, respectively, to the lower
half of the body by means of the lower body plethysmograph.
A good approach to the analysis of vascular changes could
be measurement of changes in venous pressure-volume relationships
in a model of deconditioning. Measures of venous compliance do
not necessarily reflect changes in the venous pressure-volume rela-
tionship because the compliance may be relatively constant while
the unstressed volume is changing. Nevertheless, useful measure-
ments might include serial changes in human forearm venous compli-
ance by plethysmography, and serial changes in human venous "tone"
induced by a standard LBNP protocol at selected stages of real or
simulated space missions.
In animals, measurements may be made of changes in central
venous pressure as a function of intravenous infusion of known
volumes of fluid while holding cardiac output constant by means of
the "Scher technic" (Bennett et al., 1982; Wyss et al., 1982).
This last set of measurements would provide an estimate of changes
in total systemic vascular compliance. If the cardiac output is
constant, the central venous pressure reflects the changes in pres-
sure in the systemic vascular capacitance vessels, and so systemic
compliance may be estimated as: (change in blood volume)/(change
in central venous pressure). There are no noninvasive technics
yet available for measuring vascular capacitance. The mean circu-
latory pressure approach, e.g., Drees and Rothe (1974), might be
used.
With respect to blood volume, the quantity and patterns
of shifts of blood volume between the central (thoracic) compart-
ment and the remainder of the cardiovascular system should be
determined during representative phases of actual and simulated
space flight. Provided a reliable method can be developed, abso-
lute changes in venous volume of the limbs of bed-rested subjects
should be measured with and without LBNP. An attempt should be
made to improve plethysmographic technics to enable direct assess-
ment of absolute volume changes, rather than percentage changes.
Additional studies of human hemodynamic responses to head-down
tilt should be done to expand the data base, to evaluate further
the efficacy of this procedure as a model of weightlessness, and
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to resolve apparent US/USSR differences in central venous pressure
data (Katkov, 1981; Nixon et al., 1979).
For blood volume determination, the dye-dilution technic
has proven reliable. Three good non-invasive methods for measuring
cardiac output in human subjects are carbon dioxide, acetylene, or
nitrous oxide rebreathing. Stroke volume measurements by 2-D echo-
cardiography and nuclear cardiography are well established, but of
limited precision. For more precise measurement of cardiopulmonary
dimensions, heart chamber volumes, and myocardial mass in living
subjects, more sophisticated imaging devices may be required. An
example is the Dynamic Spatial Reconstructor (DSR) which has been
developed at the Mayo Clinic (Ritman et al., 1980; Robb, 1982;
Wood, 1978; Wood et al., 1982). This system provides high speed,
synchronous, volumetric, scanning tomography. It may be feasible
to develop a scaled-down version of the DSR which would be an
affordable approach to dynamic imaging that transcends current
methods.
Other valuable imaging methods for such studies include
digital subtraction angiography, nuclear magnetic resonance (NMR),
and computerized tomographic (CT) scanning. In animal studies, a
promising approach to visualizing ventricular dynamics is biplanar
cineventriculography of the heart, in vivo, with endocardial screw
markers implanted via an intravenous catheter (Davis et al., 1980).
Concerning the mechanism that triggers vasovagal syncope, evidence
suggests that the response is related to diminished end-systolic
volume of the heart. Therefore, measurements of changes in cardiac
volume during provocative stressing should be helpful in such
studies.
Finally, the role, if any, of alterations in the CSF pres-
sure and composition in influencing cardiovascular responses should
be identified.
Because of the possibility that 20 minute exposure to
approximately 1.5 +Gz during reentry of the Shuttle Orbiter may
interfere with astronaut performance, studies of the hemodynamic
and possible associated central nervous system effects of approxi-
mately 20 minute exposures to 1.5-2.0 Gz in seated healthy human
subjects should be carried out before and after bed rest. The use
of a photoelectric earpiece and associated circuitry for contin-
uous simultaneous recordings of the blood content of the ear, the
ear opacity pulse and arterial oxygen saturation for non-invasive
monitoring of the subjects' hemodynamic status should be investi-
gated (Wood et al., 1963 b,c) along with ultrasonic methods for
detection of temporal artery flow (Sandler et al., 1977). Record-
ings of these parameters could be obtained in three types of expo-
sures in random sequence: a control relaxed exposure, an exposure
with a G-suit inflated to about 40 mm Hg, and an exposure with the
G-suit inflated while pressure breathing at a moderate level of
29
about 20 mm Hg. It would be of considerable additional value to
carry out these exposures when subjects are breathing either air
or 100% oxygen. Chest roentgenograms should be made before and
immediately after exposures to study the probable occurrence of
dependent atelectasis during such exposures and associated pul-
monary arteriovenous shunts for correlation with possible ear
oximeter arterial saturation changes.
B. EFFECTS OF SPACE FLIGHT ON CARDIOVASCULAR SYSTEM RECEPTORS
i. Current Status
The mechanical, chemical, and neurohumoral receptors
in the cardiovascular system probably have key roles in the biologic
responses to zero-G including adaptation, orthostatic intolerance,
and the deadaptation process. Precise knowledge of the effects of
weightlessness on these receptors is fundamental to progress in
elaborating the mechanisms of cardiovascular deconditioning. The
responses to excitation of the low-pressure baroreceptors hold
special interest. A possible defect in the reflex control of the
circulation, induced by zero-G, is especially important during
reentry from orbital flight and after return to the upright
posture on Earth.
The ad hoc Group reiterated the concern of many investi-
gators as to the possible role of cardiac "volume receptors" that
may act through antidiuretic hormone (ADH) release from the pitui-
,tary to induce diuresis in response to increased thoracic blood
volume--the Gauer-Henry reflex. With this proposed reflex, an
increased blood volume (or headward shift of volume) distends the
left atria and stimulates low pressure, volume receptors that have
afferent endings in the brain. The system acts to reduce ADH
secretion. This, in turn, leads to an increased urinary output of
water to reduce the blood volume. Though the concept is attrac-
tive and has been rather extensively studied, Goetz et al., (1975)
have raised doubts as to whether low pressure volume receptors
indeed have an important influence on water handling by the kidney.
Many of the technics used to increase atrial transmural pressure
also influenced cardiac output. Further, the response appears to
be transitory, and so, like the arterial baroreceptors, is probably
of minor importance in long-term control of cardiovascular homeo-
stasis. Nonetheless, the pulmonary venous and atrial receptors are
probably influenced by the headward shift of fluid during weight-
lessness; therefore, reflex changes should be studied. Goetz and
Bond (1971) reported that a reduced left atrial transmural pressure
of 6-8 mm Hg caused a 2 mm Hg increase in central venous pressure.
This suggests an influence of these atrial receptors on the capaci-
tance system, but later studies with denervated atria (vagi and
spinal afferents cut) showed similar renal responses and a decreased
arterial pressure with reduced atrial transmural pressure (see ref.,
92a in Goetz et al., 1975). The technological problems discussed by
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Goetz et al. (1975) are formidable. The possible pitfalls must be
carefully considered or else totally worthless data will be gathered
at great expense and possible risk. For example, the excitement
associated with entry into space may seriously modify or even reverse
any diuretic response.
The highly significant changes in heart rate during LBNP
stressing of spacecrews inflight or of bed-rested subjects do not
necessarily imply that the cardiovascular system is "deconditioned,"
but such an exaggerated heart rate response appears to serve as a
valuable index to the deconditioning process.
2. Critical Questions
A fundamental question is whether the atrial and ven-
tricular receptors exert regulatory control of the heart and ves-
sels and of the release of vasopressin and aldosterone during zero-G.
An important associated problem is whether weightlessness induces
changes in the number and sensitivity of the autonomic receptors of
the cardiovascular system, including the e- and 6-adrenergic recep-
tors and the muscarinic receptors. Further, if exposure to weight-
lessness results in impairment of circulatory reflex control, is the
defect that is responsible for postflight cardiovascular instability
localized in the baroreceptors, the brainstem, the afferent or
efferent limbs of the reflex arc, or in the effector cells themselves?
Increased cardiac filling pressure stimulates sensory
receptors in the atria and ventricles, the former eliciting an
increase, and the latter a decrease in heart rate. Does cardiac
filling pressure increase under zero-G conditions and, if so,
which of the foregoing effects prevails?
3. Suggested Research
The effects of real and simulated weightlessness on
the numbers and sensitivities of the mechanical, chemical, and
neurohumoral receptor sites in the cardiovascular system should be
investigated in animal and human models of cardiovascular decondi-
tioning. Progress in this area will depend heavily on advances in
methodology and instrumentation.
It is important to locate precisely the site of the defect
in the reflex control of the circulation that is responsible, at
least in part, for the cardiovascular deconditioning. Procedures
for assessing the functional changes in the reflex arcs activated
by the baroreceptors of the cardiovascular system might include
studies in _arge, non-human primates for: (a) measuring responses
of the isolated carotid sinus to analyze the afferent limb, (b)
examining the influence of surgical denervation of afferent and
efferent pathways, (c) recording responses to sympathetic nerve
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stimulation or to adrenergic agonists to analyze the efferent side,
and (d) pharmacologic blockade and responses to such maneuvers as
hand grip or a cold pressor test to evaluate the sympathetic
component.
Research should be done to develop suitable methods for
measuring baroreceptor function, per se, in conscious subjects.
This should include assays in laboratory animals for possible
changes in autonomic receptor density resulting from exposure to
weightlessness and its ground-based analogues. Test animals must
be large enough to exhibit hemodynamic responses that closely
approximate human responses. Opportunities to investigate func-
tional changes in baroreceptor reflexes are offered by studies of
subjects undergoing bed rest and other ground-based models of
weightlessness.
Lower body negative pressure, coupled With measurement
of atrial and ventricular pressures, is a means of studying the
role of atrial and ventricular mechanoreceptors in cardiovascular
function. To distinguish between low- and high-pressure receptors,
LBNP can be used to alter the activation of low-pressure cardio-
pulmonary receptors, and neck suction (Eckberg et al., 1975) can
be used to alter the activation of the high-pressure carotid sinus
receptors. The caveats and procedural guidance emphasized by
Eckberg (1982) are applicable to tests of human autonomic function
and should be considered in designing such experiments.
Past studies of histopathologic changes in the heart from
infusions of catecholamines have not emphasized possible effects
on adrenergic receptor sensitivity and density (Haft et al., 1972;
Selye and Bajusz, 1959). In view of possible imbalances of sympa-
thetic function and norepinephrine secretion during and after adap-
tation to zero-G, investigation of the effect of elevated and
depressed levels of circulating catecholamines on adrenergic recep-
tor density and sensitivity in the cardiovascular system appears
to be warranted.
C. CATABOLIC, ATROPHIC, AND HISTOPATHOLOGIC CHANGES
I. Current Status
The possibility of degenerative changes in the car-
diovascular system is a high-priority topic for resolution. Rats
exposed to weightlessness in biosatellites for 18 to 21 days have
not shown gross or histologic (light microscope) pathologic changes
(Gazenko et al., 1980). However, immobilized, horizontally-casted
monkeys and immobilized rabbits have shown histopathologic changes
in the myocardium. Somewhat similar myocardial changes were observed
in the hearts of three cosmonauts who experienced a fatal, premature
decompression of their spacecraft during atmospheric reentry after
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a 3-week mission; however, no published report of these findings
was available to the ad hoc Group. Most human data from space
flight and bed rest studies do not suggest any resultant myocar-
dial pathology, although there is good echocardiographic evidence
of diminished heart size of spacecrews after long-term missions.
2. Critical 0uestions
It is essential to know whether changes in the car-
diac mass of astronauts result from exposure to zero-G. Similarly,
the nature and extent of degenerative changes in the hearts of
immobilized animals and the causal mechanisms of such changes must
be identified as an essential part of this assessment. The possible
influence of body position should be determined, and data should
be obtained on whether there is a threshold level of whole body or
partial body hypokinesia for generation of pathologic effects in
the heart.
3. Suggested Research
Research protocols for confirming the preliminary
data on histopathologic changes in the cardiovascular systems
of immobilized animals should, if possible, be designed to dif-
ferentiate between the influence of immobilization versus that
of the body posture used to simulate zero-G; that is, to elimi-
nate, if possible, the stressful effects of the restraint system.
Otherwise, data from such studies may prove invalid for evaluating
the effects of simulated weightlessness (Burton et al., 1981).
Among the items that should be included in studies of
the myocardium are (a) the ionized calcium fluxes across the myo-
cardial cell membranes, (b) circulating levels of CPK myocardial
isoenzymes, (c) the serum transaminases, and (d) changes in myo-
cardial hydroxyproline content. As mentioned above, improved, non-
invasive methods for measuring cardiac mass and volume should be
developed. Three-dimensional echocardiography, currently somewhat
developmental, may ultimately prove a superior method, as may the
DSR, (see p.29).
The semi-isolated papillary muscle technic is said to be
advantageous for certain types of experiments on myocardial func-
tion and metabolism. For instance, the in vivo papillary muscle
in an excised dog heart is perfused with arterial blood from a
support dog in a physiologic manner at normal temperature. The
metabolic support and its experimental perturbations will be quite
analogous to natural situations. Dogs' and monkeys' papillary mus-
cles can be studied because there is no need for the muscles to be
thin as in the case of excised, diffusion-supported papillary mus-
cle preparations (Suga et al., 1977).
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Experts agree that rats are the least desirable models for
such studies, rabbits are more sensitive models, and monkeys are
probably best. However, the quest for a more suitable animal model
should not be abandoned. Members of the Working Group favored the
continued use of bed rest and other ground-based methods of simula-
tion in studies designed to detect possible changes in ventricular
mass of animal and human subjects.
D. HORMONAL AND NEUROHUMORAL FACTORS
i. Current Status
The possible relationships of the observed changes
in circulating and excreted levels of certain hormones to cardio-
vascular adaptation and deconditioning during actual or simulated
weightlessness are poorly understood. Other hormones and tissue
regulators may also be affected by zero-G such as testosterone,
pituitary growth hormone, and the insulin-like growth factors.
The negative nitrogen and calcium balances associated with space
flight are of related interest with respect to myocardial as well
as musculo-skeletal function. In addition to the suggested
research on neurohumoral and hormonal aspects of cardiovascular
deconditioning (see p.35),the Working Group took note of the
current and planned NASA studies of the hormonal aspects of bone
mineral loss, muscular atrophy, and changes in fluid and electro-
lyte homeostasis resulting from spaceflight.
2. Critical 0uestions
It is essentialto establishthe practicalsignifi-
cance of changes that have been documented in levels of circulating
and excreted hormones and whether such chan_es exert any influence
on the function of the cardiovascular system during and after
weightlessness. Are the humoral changes triggered by fluid shifts?
Does gravity exert a direct effect on biochemical processes?
The two- to four-fold increase of insulin levels in human
subjects during bed rest studies raises the questions of whether
this occurs in weightlessness and what is its practical meaning.
Does the simulated zero-G result in the release of a blocking agent?
What is the influence of an apparent increase in insulin resistance
on the metabolism of the heart and blood vessels?
One task in the NASA research program on cardiovascular
deconditioning involves investigation of the effects of sustained
cephalad fluid shifts on the pressure and composition of CSF. An
associated question concerns possible functional changes in the
pituitary portal system as a result of enduring increases in
jugular vein pressure during weightlessness.
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In view of the tendency toward decreased secretion of ADH
during spaceflight, the possible influence of this hormone on the
function of cardiovascular baroreceptors assumes added interest.
3. Suggested Research
Insulin resistance associated with actual and simu-
lated weightlessness should be quantified. The temporal changes
in serum hormone levels should be analyzed during both simulated
and actual weightlessness. Substances that should be measured
include, but are not limited to, insulin, glucagon, T3, T4, renin,
aldosterone, vasopressin, circulating myocardial CPK isoenzymes,
and fatty acids. The Working Group supports the plan for deter-
mining renin, aldosterone, and vasopressin levels in members of
Shuttle crews in future missions.
A simple glucose tolerance test, along with serum insulin
levels, could be performed in crew members during future missions.
In experimental animals, the sensitivity of glucose transport (or
transport of non-metabolized sugars) to stimulation by insulin
could be determined on isolated muscle preparations.
Preliminary findings suggest the presence of a potent
antidiuretic substance (atrial factor) in the atria of rats
(DeBold, 1981; Sonnenberg et al., 1981). This line of investiga-
tion appears to be of potential interest in cardiovascular-renal
regulation.
E. COUNTERMEASURES
i. Current Status
The Working Group recognizes the great practical impor-
tance of developing efficient and effective methods of countering the
untoward effects of cardiovascular adaptation to zero-G. Currently
available methods, including exercise, periodic exposure to LBNP,
rehydration, drugs, the anti-G suit, and combinations of these
methods require additional test and development for confirmation
of their practical utility.
The value of exercise for the prevention of cardiovascular
deconditioning has not been adequately documented. Nevertheless,
some data and considerable expert opinion suggest that exercise has
merit as a countermeasure. With regard to drugs, in bed-rested volun-
teers subjected to 60 ° head-up tilt, the beta-adrenergic blocker, pro-
panolol, reduced tachycardia, prevented a fall in arterial pressures,
and abolished the tilt-induced fall in systemic vascular resistance
(Melada et al., 1975). A calcium antagonist has been shown to exert a
favorable influence on hemodynamics in subjects deconditioned by hypo-
kinesia (Bogolyubov et al., 1978).
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2. Critical Ouestions
Knowledge of the potential of periodic exposures to
LBNP as a means of prophylaxis against certain components of car-
diovascular deconditioning is insufficient to determine whether
this approach would be a good countermeasure. What frequency and
duration of application of LBNP would be most effective? Is it
necessary to place the entire lower half of the body in a vacuum
or would lower extremities suffice? What is the most practical
means of providing LBNP for spacecrews?
Similarly, how effective is muscular exercise as a counter-
measure? Questions of the best types, patterns, and schedules of
exercise for enhancing homeostasis of the cardiovascular, musculo-
skeletal, and other organ systems and functions require further
investigation. For instance, inflight muscular exercise should
help to maintain Earth-equivalent cardiovascular function if it is
extensive enough to match the workload that prevails at I-G. Have
estimates been maOe of the magnitude of the reduced workload that
results from weightlessness?
Is it desirable to maintain tone of the abdominal muscles
in order to help control pooling of blood in the abdomen and pos-
sibly increase cerebral blood flow? There is some experimental
evidence to support the latter concept (Heite and Lerche, 1939),
but not the former (Howard, 1965). If future data indicate that
exercise improves the astronaut's ability to cope with inflight
and postflight effects of cardiovascular adaptation and decondi-
tioning, what are the optimum amounts and schedules?
What is the evidence that anti-G suits provide signifi-
cant antiorthostatic protection for astronauts during reentry in
the Shuttle Orbiter at positive accelerations of <2 Gz? Some
data, in bed-rested subjects, show that the anti-G suit protects
against orthostatic intolerance (Miller et al., 1964a,b) and pre-
serves +G z acceleration tolerance (Chambers and Vykukal, 1972;
Jacobson, et al., 1973). However, a question persists as to
whether an operational need exists for anti-G suits during reentry
of the Shuttle Orbiter (see p.29). In addition, the functional
significance of possible changes in human intrapulmonary and car-
diac morphology and performance during use of the anti-G suit is
unknown.
Drugs may offer some additional means of coping with
certain aspects of cardiovascular deconditioning. More informa-
tion is needed on the value of pressor agents and of atropine
in orthostatic intolerance.
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3. Suggested Research
The possible utility of LBNP or other methods of
influencing hemodynamics in the lower extremities deserves further
study. If data from future ground-based investigations indicate
that such technics exert a favorable effect on cardiovascular
deconditioning, additional investigations should be planned to
determine optimum methods and minimum effective schedules, and
then tested inflight. The question of whether LBNP should be com-
bined with other countermeasures, such as fluid and electrolyte
repletion, should also be investigated. If the experimental results
of LBNP or its variants are encouraging, a vigorous developmental
effort should be programmed for an optimum means of providing LBNP
to spacecrews.
Alternate means to LBNP for "hemodynamic exercising" of
the lower extremities during weightlessness are needed. For
example, the feasibility and effectiveness of inducing intravas-
cular pressure surges in the thighs and legs by repeated abrupt
decelerations in the +G z axis, such as may occur with a trampoline-
type device (Chase et al., 1966) or a mechanically-driven, whole
body oscillator (Bhattacharya et al., 1979) might be reassessed as
possible models for countermeasures. The value of using a combina-
tion of a reverse pressure-gradient garment and such an exercise
technic should be considered.
Studies of drug intervention against aspects of cardiovas-
cular deconditioning should be encouraged not only for development
of countermeasures but also as an approach toward explaining basic
mechanisms. For instance, the myocardial damage reported in monkeys
immobilized for several months may be prevented or modified by cer-
tain drugs, such as _-blockers.
Further studies are indicated on the utility of available
anti-G suits for reentry protection in the Shuttle Orbiter as well
as for postflight use. The possibility of improving the fitting
of the anti-G suit to compensate for the marked reduction of leg
volume of astronauts inflight should be explored. In addition,
further studies are needed to determine the practical effectiveness
and need for the anti-G suit for exposures of 1.5 to 2.0 +Gz for
periods of 20 to 30 minutes (see p.29). With respect to a possible
need for lower body positive pressure support postflight, a recent
report on the hemodynamic effects of medical anti-shock trousers
is noteworthy (Gaffney et al., 1981).
Similarly, in view of its documented efficacy as an anti-
orthostatic aid in short-term exposures to higher levels of +Gz,
the possible need for and feasibility of positive pressure breathing
capability during reentry of the Shuttle Orbiter should be assessed
(Rutishauser et al., 1966) (see also p.29). In addition, current
studies to evaluate body cooling as a means of resisting orthostatic
intolerance during reentry and postflight may yield sufficiently
promising results to warrant further consideration.
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F. METHODOLOGY
i. Current Status
Identification of physiological mechanisms underlying
cardiovascular deconditioning requires accurate measures of cardiac
output, central venous pressure, dynamic heart chamber volumes, and
blood, plasma, and interstitial volumes. Thus, there is a need for
more accurate methods for measuring these critical variables with
less invasive technics than were heretofore available. NASA strives
to keep abreast of advances in instrumentation and methodology that
may be applicable to investigations of the biomedical problems of
space flight.
A majority of the members of the Working Group regarded
use of available ground-based models and a search for ways to
improve them as essential for progress in this field. Because of
reasons described on page i0, one member of the Working Group was
skeptical of the fidelity of ground-based models as a means of
studying the mechanisms of cardiovascular deconditioning asso-
ciated with weightlessness.
The Working Group supported the general principle that,
whenever possible, measurements made in ground-based experiments
should be confirmed inflight, preferably in the same subjects.
Adherence to such a principle would aid in assessing the validity
of both animal and human data obtained from ground-based studies.
However, it is NASA's policy to reserve opportunities for inflight
observations only for acquiring data that cannot be obtained in
ground-based facilities. In addition, the Working Group noted the
importance of using the best available models for animal studies
and the need for seeking better animal models. In general, animals
sufficiently large to exhibit hemodynamic responses that are similar
to the human responses to simulated weightlessness are preferable
for studying cardiovascular deconditioning.
With respect to computer models of the cardiovascular sys-
tem in the weightless or bed-rest environments, the Working Group
considered the present state of knowledge of mechanisms of cardio-
vascular deconditioning inadequate for development of complex inter-
active models that could, for instance, predict an astronaut's car-
diovascular responses during various stages of a space mission.
However, incomplete, tentative models can serve useful functions
by revealing deficiencies in knowledge, indicating specific data
to be obtained, and assigning some order of priority for procuring
data.
2. Critical Questions
Important questions pertain to the subject of simu-
lating weightlessness, such as how valuable are currently-used
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ground-based models and how closely do they simulate actual space
flight? Should other environmental factors of space flight, such
as confinement in spacecraft mock-ups, use of spacecraft type envi-
ronmental control systems, social isolation, and altered light-
dark cycles, be designed into ground-based models? Do the reflex
circulatory responses associated with pressure on the skin signifi-
cantly influence bed rest as a suitable model (Takagi, 1960)?_
Use of a model of the cardiovascular system may improve
experimental design by indicating the need to include many factors
and the interactions among them, and might address such questions
as the explicit expression of our understanding of the interrela-
tionships of all the major factors involved in cardiovascular
deconditioning. To what extent are the cardiovascular changes
accounted for by blood volume changes? How much blood volume
repletion is desirable? How much of a role do baroreceptors play?
How much do changes in venous compliance or capacity influence
cardiovascular responses?
Finally, a question arose regarding the value of studying
animals immobilized for long periods. It was considered that the
associated psychological stress might invalidate such models for
the study of cardiovascular deconditioning (Burton et al., 1981).
3. Suggested Research
The Working Group stressed the need for improving
methods for both direct and indirect measurements of cardiovascular
parameters that are essential in NASA's investigations, and empha-
sized standardization of methodology as an aid to acquisition of
compatible, reproducible data and to minimize some experimental
variables. Functions and characteristics of the cardiovascular
system for which improved methodology is needed for use in living
subjects in actual and simulated zero-G include: myocardial mass,
heart chamber volumes, cardiopulmonary dimensions, absolute changes
in venous volumes and capacitance, plasma volumes, interstitial
and total body water, and the densities and sensitivities of the
mechanical, chemical, and neurohumoral cardiovascular receptors.
An example of a type of instrumentation development that
is of interest to NASA is that of J.D. Hestenes (O'Handley, 1982)
on a method of extracting physiologic features from cardiac and
arterial ultrasound images. J. Hines and H. Sandler (Sandler,
1982b) are miniaturizing, repackaging, or redesigning already
* Additional references on circulatory responses to skin pressure
may be obtained from Dr. Sagawa whose full name and address are
listed in Section VIII.
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available biotelemetry systems for use in small laboratory ani-
mals, for space flight studies. A third example is the work of
J.L. Lacy (Bungo, 1982) to improve cardiac imaging by means of
tantalum 178, a radionuclide that offers certain advantages over
other radioisotopes used in cardiac imaging, such as a relatively
short radioactive half-life.
Efforts should be continued to evaluate the efficacy of
and to improve ground-based models of weightlessness. Attempts
should be made to assess the effects of gravity-induced pressure
gradients and associated blood volume and flow throughout the sys-
temic and pulmonary circulations on the validity of bed rest as a
model of weightlessness. In designing and interpreting experiments
on the effects of simulated weightlessness and hypokinesia, inves-
tigators should bear in mind that physiologic changes evoked by
otherwise unrestrained resting conditions may differ from those
elicited by immobilization.
With respect to computer models, the Working Group sug-
gested that incomplete, tentative models theoretically would be
helpful to investigators, as mentioned above. For example, the
models described by Snyder and Rideout (1969), which incorporated
gravitational force, and Shoukas and Sagawa (1973), which distin-
guished between compliance and capacity, could be useful. In addi-
tion, the models described by Guyton et al. (1972), Coleman et al.
(1974), Randall (1980), and Rothe (1982) could be helpful. A
modeling program that has yielded interesting results in relation
to biomedical effects of space flight is based upon Guyton's orig-
inal model (Guyton et al., 1972) and other models of the circula-
tion. It involves a systems approach to defining human responses
to the environment of space flight and to the formulation and
testing of associated hypotheses (White et al., 1982).
The current model of "Human-80" is probably the most
sophisticated model now available of the human body in health,
disease, and during treatment. Cardiovascular, respiratory,
renal, endocrine, and reflex factors are included. It is based on
Ouyton's model described in 1972, has 479 variables, yet can be
run on a microcomputer as well as on larger systems.* Any model
would have to be modified to simulate the effects of weightlessness,
but this extensively used and sophisticated model would provide a
good foundation.
* Dr. James Randall (Department of Physiology and Biophysics, Myers
Hall, Indiana University, Bloomington, IN 47405) or Dr. Thomas G.
Coleman (Department of Physiology and Biophysics, University of
Mississippi Medical Center, Jackson, MS 39216) could provide
further information.
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VI. PROPOSED PRIORITIES OF SUGGESTED RESEARCH AND ANALYSIS
The main objective of the NASA ground-based research and
analysis program in cardiovascular deconditioning is the acquisi-
tion of scientific data that will lead to practical methods of pre-
vention or control of the syndrome. The current lack of adequate
data indicates clearly the continuing need for investigations
focusing on the biological mechanisms involved and improvement of
technics, methods, equipment, and facilities to further such
endeavors.
The research and analysis concepts listed in Table 6 were
derived from the deliberations of the ad hoc Working Group. The
categories in Table 6 are interrelated and were all considered as
important programmatic components; however, within the six separate
categories, the suggestions for research emphasis are presented in
a decreasing order of priority.
In addition, the Working Group recognizes the need for
unequivocal confirmation of the methodologic suitability of the
currently-used or alternate ground-based models of the space
flight environment, particularly with respect to weightlessness.
The fundamental importance of this question may justify its formal
treatment as a distinct program element with designated managerial
responsibility. Finally, the untoward effects on cardiovascular
system function that have been observed during the first days and
weeks immediately following long space missions, the lack of
knowledge of the underlying biologic mechanisms involved, and the
unproved efficacy of currently available countermeasures all
emphasize that solution of the problem of cardiovascular decondi-
tioning justifies a high priority within NASA research and
technology programs.*
* One member of the LSRO ad hoc Working Group suggested that this
section required altered emphasis (see Appendix, p.67-69).
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Table 6. Suggested Priority of NASA Ground-Based Research and
Development in Cardiovascular Deconditioning*
A. HEMODYNAMICS
o Assess cardiovascular function, using multiple end
points, at selected stages of simulated space missions,
including the first 24 hours.
o Determine whether cardiac filling pressure increases or
decreases in simulated weightlessness and characterize
its time course.
o Characterize changes induced by simulated weightlessness
on cardiopulmonary blood pressure relationships and their
influence on cardiovascular deconditioning.
o Measure changes in total vascular capacitance in human
and animal models of cardiovascular deconditioning.
o Determine changes in regional systemic and pulmonary blood
volumes and blood flows and their effects on cardiovascular
functional capacity in a model of deconditioning.
o Determine whether intraabdominal pressure changes occur
in simulated weightlessness and whether abdominal muscle
tone influences hemodynamics.
o In ground-based studies, determine the operating point of
the heart in relation to the Frank-Starling curve.
B. ENDOCRINE AND NEUROHUMORAL ASPECTS
o Formulate experiments to' detect the effect on cardiovas-
cular system function associated with changes in levels
of circulating and excreted hormones that have been
observed in real and simulated weightlessness.
o Perform detailed, serial analyses of temporal changes in
serum hormone levels in bed-rested subjects during simu-
lated space missions. Candidate substances should include
insulin, glucagon, catecholamines, T3, T4, renin, aldo-
sterone, vasopressin, myocardial CPK isoenzymes, fatty
acids, cholesterol, and high- and low-density lipoproteins.
* Listed in suggested decreasing order of priority withi_ each of
six separate categories. See Section V, A-F for detail.
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Table 6 (continued)
o Study the influence of atrial and ventricular sensory
receptors on regulation of cardiovascular function and
on release of vasopressin and aldosterone in simulated
weightlessness.
o Further define and quantify insulin resistance associated
with simulated weightlessness.
o Measure changes in intracranial vascular and cerebrospinal
fluid (CSF) pressures associated with simulated zero-G.
Correlate the changes with alterations in CSF composition,
pituitary portal system function, and regulation of the
cardiovascular system.
o Study the functional relationship between vasopressin and
cardiovascular system baroreceptors.
o Design experiments to differentiate between hypokinesia
and simulated weightlessness in the induction of hormonal
changes associated with space flight.
o Study the effects of elevated or depressed catecholamine
concentrations on adrenergic receptor density and sensi-
tivity in the cardiovascular system if sfgnificant varia-
tion in circulating levels of catecholamines can be induced
in a model of deconditioning.
C. MYOCARDIAL CHANGES
o Characterize the myocardial changes that have been
reported in chronically immobilized animals. Identify
temporal aspects and specific etiologic factors.
o In studying the effects of simulated weightlessness on
the heart, consider measuring changes in: (a) ionized
calcium fluxes across the myocardial cell membrane, (b)
circulating levels of CPK myocardial isoenzymes, and (c)
myocardial hydroxyproline content.
o Differentiate between tile myocardial and hemodynamic
effects of immobilization versus postural, immersion, or
other methods of simulating zero-G in animal models of
cardiovascular deconditioning.
D. RELATED FACTORS
o Locate the sites of possible defects in reflex control
of the circulation that contribute to cardiovascular
deconditioning,
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Table 6 (continued)
o Assess the relative importance of high- and low-pressure
baroreceptors in the reflex control of the circulatic)n
during and after weightlessness.
o Determine in an animal model of cardiovascular decondi-
tioning whether changes occur in the density and sensi-
tivity of the cardiovascular adrenergic receptors in
response to simulated weightlessness.
o Determine the relative importance of physical inactivity
dictated by the spacecraft dimensions and personal protec-
tive equipment versus weightlessness in the induction of
cardiovascular deconditioning.
o Study the relationship between end-systolic volume of
the heart and vaso-vagal syncope as an approach to identi-
fying the "trigger" mechanism of syncope.
o Conduct studies of human subjects during bed rest in
order to investigate the functional changes in baro-
receptors.
E. METHOI)S, EQUIP_ENT, AND FACILITIES
o Improve the methods of measuring in living subjects such
characteristics as cardiopulmonary dimensions, heart
chamber volumes, myocardial mass, plasma volumes, erythro-
eyte mass, and interstitial and total body water.
o Design experiments with LBNP coupled _ith measurement of
atrial and ventricular pressures in order to study the
role of associated mechanoreceptors in cardiovascular
function. LBNP activates low-pressure receptors and neck
suction activates the high-pressure receptors.
o Refine the methods of measuring baroreceptor function,
per se, in conscious subjects.
o Assess the influence of gravity-induced pressure
gradients throughout the body on the efficacy of ground-
based models of weightlessness.
o Develop methods to measure absohtte changes in venous
volume and venous capacitance of bed-rested subjects.
o Develop a method for analysis of the responses of low-
pressure baroreceptors in simulated weightlessness.
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€ Conduct further validation studies of head-down tilt bed
rest as a method of simulating weightlessness.
o Assess the possible need for improving the fidelity of
ground-based facilities for human studies by incorporating
such items as spacecraft mockups, environmental control
systems, and social isolation.
o The search for better animal models for studies of cardio-
vascular deconditioning should continue. Preferably, the
animal should be large enough and of a morphology to have
hemodynamic responses similar to human responses. Rats
appear to be poor models for such studies; large monkeys
and chimpanzees are probably the best yet identified.
o Encourage investigators to use models of the cardio-
vascular system when they design experiments on cardio-
vascular deconditioning, even though available knowledge
of the mechanisms involved is incomplete.
F. COUNTERMEASURES
o Expand the test and development of extant types of putative
countermeasures to confirm their possible efficacy and to
refine their patterns and means of use. Examples of puta-
tive measures are muscular exercise, LBNP, fluid and salt
repletion, and combinations of these.
• Develop alternate means for stressing the vascular system
of the lower extremities during weightlessness.
o Perform tests with deconditioned subjects to determine
whether the anti-G suit is a practical countermeasure
to decelerative stress during Shuttle Orbiter reentry.
o Develop the means to assure precise fitting of the anti-G
suit for the lower extremities of spacecrews if studies
indicate that the anti-G suit offers practical reentry
protection in the Shuttle Orbiter.
e Determine the optimum frequency and duration of LBNP as a
prophylactic countermeasure for cardiovascular decondition-
ing in bed-rested subjects. Determine the minimum amount
of body exposure to LBNP below the thorax that is necessary
for a preventive effect.
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e Formulate experiments to test the utility of drugs and
hormones as prophylactic or therapeutic countermeasures
to the orthostatic intolerance of cardiovascular decon-
ditioning.
o Design a study of astronauts to (i) identifF those who
demonstrate relative resistance to cardiovascular decondi-
tioning as may be estimated from inflight and postflight
physiologic responses, and (2) to define physiologic and/or
behavioral correlates of such resistance.
• Estimate the amount of muscular exercise required in
spaceflight to equal the work done in selected amounts of
muscular exercise on Earth. Apply findings to the design
of ground-based tests of the utility of muscular exercise
regimens.
• Reassess the possible need for and feasibility of using
positive pressure breathing equipment in conjunction with
the G-suit during reentry of the Shuttle Orbiter.
• Perform measurements in bed-rested subjects of possible
changes in cardiopulmonary morphology induced by use of
the anti-G suit, and estimate their significance.
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MINORITY OPINION*
Page vii - third paragraph
"Critical questions and suggested research
Since it seems quite certain that elimination of hydrostatic gradients in
the venous circulation and a consequent increase in right atrial and probably
left atrial pressures caused by the resulting central ward shift of circulatory
blood volume is the initiating factor of the hemodynamic effects of zero gravity
it is of highest priority to obtain measurements of right atrial pressures
during and after the onset of the zero-G environment.
Without information concerning the magnitude and time course of these pre-
sumed changes in right atrial pressure the significance relative to space
flight of ground-based models which do not produce closely similar changes
cannot be assessed.
Other considerations deserving high priority include: (I) whether degenera-
tive changes occur in the cardiovascular system during medium- and long-term
missions, in particular, a possible loss of myocardial mass, (2) the nature and
temporal development of changes in cardiovascular regulatory control mechanisms,
(3) possible changes in the density and sensitivity of the pressure, volume,
and neurohumoral receptors in the cardiovascular system, (4) alterations in
vascular compliance and capacity, (5) associated changes in hemodynamics, and
(6) the nature of the redistributed blood flows."
Page i0 - third paragraph should read as follows:
"The serious deficiencies of earth based models of the zero gravity environ-
ment are generally over looked or minimized. They are however of such magnitude
that the relevance of observations using these models to the zero gravity situ-
ation is at best open to serious question and, at worse, of no practical signi-
ficance relative to space flight.
It is true that a partial shift of blood volume from the lower extremities
headward can be produced by water immersion and by the horizontal or 5° head
down position. However, this is not an adequate simulation of the zero G
condition.
* The text and references of the Minority Opinion are presented as
submitted, without editing (M.N.L., J.M.T.).
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This is because no currently conceivable stationary earth based mode! can
mimic the multiple other important effects of zero-G resulting from the absence
of the affects of gravity on:
i) The spatial distribution of pulmonary blood volume and flow
particularly in the vertical direction (i-4) as well as dependent
hydrostatic capillary filtration. All of which, because of the
approximately 15-20 cm transverse diameters of the lungs as compared
to the 20-30 cephalo-caudad dimension, are only moderately reduced in
the horizontal position at i G and are unchanged during head-up water
immersion.
2) The dimensions, shape and position of the diaphragm and thoracic cage,
i.e. lung volume (5).
3) The shape and positon of the heart and its chambers.
4) The spatial distributions, particularly the vertical gradient, in
atrial and ventricular transmural pressures which differ in direction
but are of similar magnitude irrespective of body position at 1G (6-8).
5) The spatial distribution of respiratory gas volumes and flows
particularly in the vertical direction (9, I0).
6) The spatial distribution, particularly the vertical gradient, in
pleural pressures which is present to a significant degree in all body
positions (11-18).
7) Pooling of blood and increased hydrostatic capillary filtration in
dependent regions of the systemic vasculature which, because of the
5-25 cm transverse dimensions of the human body, are significant even
in the horizontal position.
8) The vertical gradient in intra-abdominal pressures which is present to
a significant degree in all body positions (19, 21).
9) The vertical gradient in cerebrospinal fluid pressures which is also
present to a significant degree in all earth-bound body positions.
This list of deficiencies of a!l currently conceivable stationary earth
based models of zero gravity is arranged in descending order relative to their
probable hemodynamic significance.
This hierarchical arrangement stems from the fact that the effects of gravity
on the spatial distribution of pulmonary blood and gas volumes and flow, position
of the heart and diaphragm, and dependent (hydrostatic) pulmonary pooling and
capillary filtration cannot be avoided by either bed rest or water immersion.
These effects of gravity on the heart, lungs and great vessels are probably of
major importance in the adaptation of humans to the 1G force environment of
planet earth. This is because the heart, lungs, and great vessels are the most
compliant segments of the vascular system, and hence are the major recipients
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of a zero G medicated cephalad shift in blood volume. In addition, unlike zero
gravity, the volume of the thoracic cavity is reduced by upward displacement of
the diaphragm during either water immersion or bed rest. These multiple differ-
ences highlight the fact that all currently conceivable earth-bound models fail
to simulate many of the majorly important hemodynamic and pulmonary aspects of
the agravic environment.
Use of animal models as surrogates for unanesthetized humans relative to
the effects of changes in the magnitude and/or the direction of the gravita-
tional-inertial force environment is equally discouraging in relation to
obtaining practically important information relative to human space flight
problems (20).
Just as proved to be the case relative to studies of the +G z black-out
problem during World War II, it is likely that none or at best only a very
limited category of results from animal studies will prove to be of practical
importance to human space flight. Furthermore it is possible, as occurred
during World War II, that results from animal studies may actually be misleading
relative to human flight problems (21, 22).
Since bodily dimensions are of primary importance relative to susceptability
to changes in the force environment (e.g. mice can survive exposures to 400 G)
the bodily dimensions and shape, particularly of the thorax, of animal surrogates
should be closely similar to humans.
These considerations lead to the conclusion that NASA's research program to
elucidate zero G induced cardiovascular deconditioning should be focused primarily
on the stimulation and support of studies which carry the highest potential of
obtaining quantitative accurate measurements in humans of the changes in the most
important physiologic parameters relative to the acute and chronic hemodynamic
and resulting associated effects of space flight. This essential information
is at present either missing or not well documented.
The essential missing information relative to the magnitude and time course
of the hemodynamic effects of the zero G environment in order'of importance are:
i) right atrial pressures, 2) the magnitudes and
spatial distributions of pulmonary blood and gas
volumes and flows, 3) the associated changes in
left atrial pressures, 4) position, shape and
pressure-volume dynamics of the cardiac chambers,
5) shape and position of the diaphragm and
associated lung volumes, 6) possible changes
in myocardial mass.
It is highly probable that, except for psychological and psychosomatic
factors, most or all of the other effects of the zero G environment on the
heart, lungs, circulation, body fluids electrolytes and related neurohumoral
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changes are initiated by the absence of hydrostatic circulatory, body fluid and
tissue pressure gradients which pertains at the onset and for the duration of
space flight.
It is therefore of primary importance that the effects of the absence of
hydrostatic pressure gradients particularly in the most mobile organ of the
body, i.e. the blood and its effects on the major segments of the circulatory
system, be measured accurately, and as non-invasively as possible, in healthy
humans at the onset and during space flight along with essential control
measurements just prior to and after the zero G exposure.
Certainly definitive studies of these effects of microgravity in man as
well as large animals will require accurate minimally invasive measurements of
atrial filling pressures along with cardiac chamber volume dynamics, myocardial
mass, spatial distributions and magnitudes of systemic, pulmonary and coronary
blood volumes and flows plus the shape and position of the diaphragm andthe
associated spatial distributions and the magnitudes of pulmonary gas volumes
and flows (ventilation).
High speed, accurate three dimensional reconstruction of the dynamic
anatomy and the resulting synchronous functional dynamics of these organ
systems which can be obtained by high speed synchronous volumetric scanning
tomography is the only currently conceivable system which will provide the
unique capabilities required for making accurate, minimally invasive, syn-
chronous measurements of these parameters in intact animals and humans
(23-27) ."
Page i0 - suggest fourth paragraph read as follows:
"Blomqvist and Stone (1983) note that a marked change in the hydrostatic
conditions that prevail in the systemic circulation in humans in the upright
positions on Earth results when subjects are exposed either to experimental bed
rest and to head-out immersion in water. However, the inability to duplicate
the complete absence of all hydrostatic effects in all tissues and segments of
the circulation, particularly and very importantly within the thorax, which
pertains at zero-G is a serious deficiency of all stationary ground based
models. A redistribution of intravascular and interstitial fluid from the
lower to the upper half of the body is one of the major, acute, hemodynamic
effects of both zero-G and its ground based models. Presumably therefore the
mechanisms for adaptation to the relocated fluids and altered intravascular
pressures associated with bed rest, and water immersion, may be similar to the
effects of zero G. In any event, hypovolemia, reduced stroke volume and
cardiac output, orthostatic intolerance, and decreased exercise capacity are
the common results of exposure to real and simulated weightlessness (Blomqvist
and Stone, 1983)."
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Page 41 - the following should be added after the last paragraph:
"A suggested set of efforts listed in order of priority for a NASA research
and development program designed to elucidate the mechanisms and methods for
prevention of the cardiovascular deconditioning associated with exposures to
zero G follows:
i) It is an accepted fact that a cephalad shift
of blood volume occurs uniformly at the
onset of exposures to zero G. It is also
suspected but not firmly documented that an
increase in right atrial filling pressure
occurs at this time.
Since this is the initial major hemodynamic
effect of exposure to zero G and is probably
responsible for most or many of the changes
which are responsible for the cardiovascular
deconditioning which follows, it is of
critical importance and of highest priority
that accurate measurements of the magnitude
and the time course of changes in right
atrial pressures be obtained beginning as
soon as possible after the onset of zero G.
2) Since accurate studies of these effects
would be greatly facilitated if the hemo-
dynamic effects of zero gravity could be
faithfully simulated in a ground based
environment it is of next highest priority
to determine if closely similar changes in
the magnitude and time course of possible
changes in right atrial filling pressures
occur in the most frequently used ground
based simulations of weightlessness namely:
horizontal bed rest, 5° head-down bed rest,
and water immersion to the neck. If closely
similar changes in right atrial filling
pressure do not occur under these circum-
stances the pertinence of results of studies
of these ground based models relative to the
hemodynamic, pulmonary and subsequent
effects of zero gravity may be close to
zero.
3) Since quite certainly the cephalad shift in
blood volume at the onset of an exposure to
zero gravity is associated with: i) changes
in position, shape, dimensions, and pressure-
volume dynamics of the cardiac chambers and
6?
2) changes in the magnitudes, and spatial
distributions of pulmonary blood and gas
volumes and flows and 3) the shape, position
of the diaphragm and thoracic cage with the
resultant changes in regional and total lung
volumes, and at present there are no accurate
technics for minimally invasive measurements
of these parameters in intact large animals
or humans, it is of next highest priority to
develop adequate instrumentation and tech-
niques to obtain these measurements. The
number 3 priority rank of this task holds
irrespective of the outcome of priority 1
and 2 tasks.
The only known method with the capabilities
of minimally invasive, nearly simultaneous
measurements of this battery of physiologic
parameters is the technic of non-invasive
vivisection of quantitative, dynamic, three
dimensional images of the thorax and its
contents obtained by high speed synchronous
volumetric scanning tomography (23-32).
4) Utilize these and associated measurement
technics to determine the probable signifi-
cance of the differences in the hemodynamic
and pulmonary effects produced by zero G and
the most commonly used methods for ground
based simulations of the space flight
environment.
5) Utilize these same measurement technics to
study the mechanisms and the effectiveness
of various counter measures to the zero G
environment particulary LBNP and exercise.
6) Because of the probability and some evidence
that 20 minute exposures to 1.5-2.0 +G z during
reentry from space shuttle flights may inter-
fere with astronaut performance, studies of
the hemodynamic and possible associated CNS
effects of approximately 20 minute exposures
to 1.5-2.0 +G z in seated healthy humans
should be carried out before and after bed
rest.
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The use of a photoelectric earpiece and associated
circuitry for continuous simultaneous recordings
of the blood content of the ear, the ear opacity
pulse and arterial oxygen saturation for non-
invasive monitoring of the subjects hemodynamic
status should be investigated (33-35) along with
ultrasonic methods for detection of temporal
artery flow (36).
It would be of considerable physiologic and also
of practical value to obtain recordings of these
parameters in three types of exposures in random
sequence: a control relaxed exposure, and
exposure with a G suit inflated to about 40 mm Hg,
and an exposure with the G suit inflated while
pressure breathing at a moderate level of about
20 mm Hg.
It would also be of considerable additional value
to carry out these exposures when breathing air
and when breathing 100% oxygen with chest
roentgenograms before and immediately after the
exposures, to study the probable occurrence of
dependent atelectasis during such exposures (34)
and associated pulmonary arteriovenous shunts for
correlation with possible ear oximeter arterial
saturation changes (14-16)."
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